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Abstract 
Cell-cell interactions in situ during the early phase of T cell priming 
M.Hommel, Dept. of Cellular Immunology, DKFZ Heidelberg, Germany 
 
Successful induction of an adaptive immune response depends on antigen dose, the duration 
of antigen presentation and the cellular environment in which antigen is presented. These 
parameters may vary according to the particular epitope recognized by T- or B-cells. 
However, the in situ behaviour of clonal or polyclonal T cell populations during the immune 
response has only recently become amenable to precise experimental analysis. Here, we 
isolated and characterized T cell/APC clusters as a functional compartment of initial T cell 
proliferation. This way, it has been possible to bridge existing in vitro and in situ studies. 
Cluster formation was found to occur independent of specific antigen application and 
included segregation of recent lymph node immigrants (measured as CD62L down-
regulation). Furthermore, initiation of T cell proliferation could be attributed to clusters and 
was followed by cell-cell contact-independent division at later stages of clonal expansion. 
This finding was confirmed in six different transgenic models including both T cell lineages 
(CD4, CD8) as well as two different MHC backgrounds (H2b, H2d). Interestingly, even 
though all transferred T cell populations could be localized in clusters at the same time, 
completion of the first round of cell division of T lymphocytes specific for a subdominant 
epitope and a weak agonist lagged behind that of cells specific for dominant epitopes. The 
T cell wave needed approximately 32-36 hours to pass through the cluster ‘compartment’. 
These results concomitant with current literature provide a basis to combine and extend 
current ideas in a revised model of T cell activation. 
In addition, the hCRP model allowed addressing the mutual influence of T cell populations 
specific for epitopes of the same protein. Using the method of cluster isolation, it could be 
shown that both populations recognize their antigen on the same APC – an important 
prerequisite for events such as linked help or suppression. Linked help towards the 
subdominant epitope could be observed in a situation in which antigen was transiently 
available but not under prolonged transient antigen availability. 
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Abstract (German) 
Zell-Zellinteraktionen in situ während der frühen Phase der T-Zellaktivierung 
M.Hommel, Abteilung Zelluläre Immunologie, DKFZ Heidelberg, Deutschland 
 
Die erfolgreiche Induktion einer adaptiven Immunantwort ist von der Antigendosis, der Dauer 
der Antigenpräsentation sowie der zellulären Umgebung, in der das Antigen präsentiert wird, 
abhängig. Diese Parameter können je nach Epitop, das von T- oder B-Zellen erkannt wird, 
variieren. Das in situ Verhalten klonaler oder polyklonaler T-Zellpopulationen im Verlauf 
einer Immunantwort ist erst in den letzten Jahren einer eingehenderen Untersuchung 
zugänglich geworden. In dieser Arbeit wird die Isolation und Chrakterisierung von 
T-Zell/APZ-Clustern als funktionelle Einheit der initialen T-Zellantwort beschrieben. 
Die Clusterbildung fand unabhängig von spezifischer Antigengabe statt und beinhaltete die 
Segregation von Zellen, die erst kürzlich in den Lymphknoten eingewandert waren (gemessen 
als Abnahme der Oberflächenexpression von CD62L). Desweiteren konnte die Initiation der 
T-Zellteilung Clustern zugeschrieben werden und ging zu einem späteren Zeitpunkt in eine 
vom DZ-Kontakt unabhängige Proliferation über. Diese Beobachtung konnte in sechs 
verschiedenen transgenen Modellen bestätigt werden, die sowohl beide T-Zelllinien (CD4, 
CD8) als auch zwei verschiedene MHC Haplotypen (H2b, H2d) einschlossen. Obwohl 
T-Zellen aller Modelle zur gleichen Zeit in Clustern lokalisiert werden konnten, benötigten 
T-Lymphozyten, die ein subdominantes Epitop und einen schwachen Agonisten erkennen, 
länger, um ihre erste Zellteilung zu vollenden, als Zellen die spezifisch auf ein dominantes 
Epitop reagierten. Die ‚T-Zell-Welle’ durchlief das Cluster-Kompartment in etwa 32-36 
Stunden. Diese Resultate stimmen mit aktueller Literatur überein und bieten einen Ansatz, 
derzeitig diskutierte Modelle miteinander zu verbinden und zu einem revidierten Modell der 
T-Zellaktivierung zu erweitern. 
Darüberhinaus erlaubt das hCRP-Modell, den gegenseitigen Einfluß zweier 
T-Zellpopulationen, die Epitope desselben Proteins erkennen, zu untersuchen. Mit Hilfe der 
Clusterisolation konnte gezeigt werden, daß beide Populationen ihr Antigen auf derselben 
APZ erkennen – eine wichtige Voraussetzung für ‘linked help’ oder ‘linked suppression’. 
Unter Bedingungen, in denen Antigen nur über sehr kurze Zeit verfügbar ist, konnte ‘linked 
help’ für Zellen, die gegen das subdominante Epitop gerichtet sind, gezeigt werden. Dieser 
Einfluß ging verloren, sobald das Antigen über etwas längere Zeit vorhanden war.
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Introduction 
1 Basic Concepts in Immunology 
 
In higher organisms the immune system can be divided into two functional units, namely the 
innate (natural) and the adaptive (acquired) one, both working closely together. Innate 
immunity provides the first barrier for infections, eliminating most of the pathogens before 
serious damage can occur. It is mainly non-inducible and displays neither (or only partial) 
specificity nor memory functions. Therefore susceptibility remains the same even after 
repeated infections. The components of the innate immunity are of both soluble (lysozyme, 
complement, acute phase proteins such as C-reactive protein (CRP) and interferons) and 
cellular nature (macrophages, neutrophils and natural killer cells (NK cells). In case a 
pathogen manages to slip through this line of defense, the adaptive response takes over. Due 
to the work of Pasteur, Koch, Metchnikoff and other microbiologists, its characteristic 
features were identified: firstly, it is inducible i.e. the system responds specifically to 
antigens. Secondly, the most striking feature is the generation of an immunological memory, 
leading to the accurate recognition of an antigen upon re-infection. Quite often an adaptive 
immune response provides life long protective immunity (Golub and Green, 1991). There are 
several mechanisms working together in such a response, and they involve humoral as well as 
cellular components. Families of antigen binding molecules that are expressed on or produced 
by lymphocytes determine specificity, diversity and memory: immunoglobulins (antibodies) 
and T cell receptors (TCRs). Cellular immunity involves the activity of inflammatory T helper 
lymphocytes, which are able to lyse infected cells upon recognition of foreign antigens 
presented on their surfaces. The humoral immune response is based on specific antigen-
binding soluble factors called antibodies that are produced by B lymphocytes. Due to the 
nature of their development, it was long thought that each B- and T cell is restricted to 
recognize a single antigen but this has been proven not to be true (Mason, 1998). As a 
population the cells of the immune system possess millions of specificities (the theoretical 
diversity of the pre-selection repertoire mouse or human αβ T cell repertoire, i.e. before its 
shaping by selection for self-MHC-recognition and avidity, has been estimated at about 1014, 
Davis and Bjorkman, 1988). A population of resting T cells is activated only after specific 
antigenic stimulation leading to one of the fundamental features of immune responses: 
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 proliferation. This process is called clonal selection (Burnet, 1959) and the basic premises of 
this theory are (paraphrased from Burnet, 1969): 
 
– existence of cells differentiated for immune function being evident by their ability to 
react with specific antigen, 
– determination of the antibody specificity by the genetic endowment of the cell 
producing it, 
– sharp limitation of the range of immune reactivity of any lymphocyte by a process of 
phenotypic restriction, 
– origin of the diversity of immune specificity having to be sought at the genetic level, 
– antigen acting essentially as a signal or stimulus to such cells that are competent by 
expressing specific receptors to it. 
 
Under the influence of T cells and monocytes, B cells differentiate into antibody secreting 
plasma cells and memory cells. 
All cells involved in immune responses are sequestered in lymphoid and non-lymphoid 
organs or circulate through the body. Primary lymphoid organs are important for the 
differentiation of pluripotent stem cells into T- (thymus) and B cells (Bursa Fabricius) 
whereas secondary lymphoid organs such as lymph nodes, spleen and lymphatic tissues 
associated with mucosa (Peyer’s patches, gut, lungs and tonsils) provide sites for the initiation 
of an adaptive immune response. Different lymphocytes inhabit different regions of these 
organs and trafficking is mediated by homing receptors on their cell surface (Janeway and 
Travers, 2001). 
 
2 T cell Biology 
2.1 Basic Concepts of T cell Activation 
2.1.1 The T cell Receptor 
T cells are the main carrier of cell-mediated immunity and have an important regulatory 
function in humoral immune responses. As mentioned above, specificity is provided by the 
cell surface expression of receptors. Each mature T cell bears approximately 40,000 T cell 
receptor molecules (Meuer et al., 1982), which are composed of two disulfide-linked, 
glycosylated polypeptide chains forming a heterodimer. The vast majority of mature 
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 lymphocytes in mice express receptors composed of α- and β-chains, only very few bear the 
alternative type of a γδ heterodimer (2-5% of murine peripheral T cells): While the former 
clearly mediates antigen recognition, the function of the latter is about to be fully elucidated 
(Schild et al., 1994). The T cell receptor displays homology to a membrane-bound fragment 
of immunoglobulins, and therefore it is not surprising that B- and T cells recruit the same 
mechanisms operating on homologous genes to generate these molecules. Analogous to the 
heavy and light chains of the B cell receptor, the formation of mature antigen receptors on 
T cells is a result of somatic recombination of separate gene segments. In α-chains, one of 
multiple V-(variable) elements is coupled to an adjacent J-(joining) element, which in turn is 
joined to the only exon encoding the C-(constant) region. In β-chains an additional 
D-(diversity) segment is included to give V(D)J exons, which then are also joined to a 
C-element. While there is only one Cα gene, two Cβ genes are known. Nevertheless, no 
functional difference between their products could be identified. This so-called TCR-
rearrangement requires mechanisms acting very precisely (but still not perfect) to ensure only 
corresponding gene segments are joined to each other: recombination signal sequences (RSS) 
determine the site of cleavage, which is performed by proteins that introduce double strand 
breaks. Some of these proteins are encoded by recombination activating genes (RAG1 and 
RAG2). Improper joining of the segments, i.e. by the addition of P-(palindromic) and N-(non-
templated) nucleotides increases TCR diversity. The actual variability is concentrated in the 
so-called complementarity determining regions (CDRs), with CDR1 and CDR2 being 
encoded within the V segments themselves, while CDR3 is located at the position of the P- 
and N-nucleotides. Unlike B cells, T cells do not extend receptor diversity by somatic 
hypermutation upon antigen contact. Most T cells are restricted to the production of a TCR of 
only a single structure even though they actually have the potential of producing two different 
ones (about one third of the T cell population expresses two α-chains (Padovan et al., 1993)). 
This process of making use of only one of the two chromosomes is referred to as allelic 
exclusion. The cytoplasmatic domain of the TCR is rather short and thus lacks sufficient 
signaling capacity. It is non-covalently associated with a complex of invariant proteins, 
collectively termed CD3 complex, which are involved in signal transduction. 
 
2.1.2 Antigen Recognition 
In contrast to B cells and antibodies, T cells are not able to recognize antigen in its native 
form but depend on peptide fragments that are presented by molecules of the major 
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 histocompatibility complex (MHC) on the surface of antigen presenting cells (APC) 
(Cresswell and Howard, 1997). The specificity of a TCR for a given MHC allelic product is 
referred to as MHC restriction.  
The discovery of the MHC was based on it encoding transplantation antigens inducing 
rejection of tissue transferred from one individual to another (Gorer et al., 1936). The MHC 
is, in fact, one of the most highly polymorphic gene complexes known and is not only multi-
allelic, but also multigenic. The alleles are numerous, divergent, and evenly distributed within 
populations (Parham and Ohta, 1996). MHC class I molecules are expressed constitutively on 
most somatic nucleated cells or, if not, can be induced by lymphokines such as interferon γ. 
They present endogenous self-proteins and viral proteins produced by the cell’s biosynthetical 
machinery in the cytosol (Janeway and Travers, 2001). The expression of MHC class II 
molecules is restricted to professional antigen presenting cells such as dendritic cells (DC), 
B cells, activated macrophages (Mφ), cortical (cTEC) and medullary (mTEC) epithelial cells 
of the thymus (Hämmerling and McDevitt, 1974; Hämmerling et al., 1975; Rouse and 
Weissman, 1982). MHC class II molecules mainly present peptides derived from proteins that 
have been endocytosed and processed by APC. There is evidence that exogenous antigens are 
also presented on MHC class I molecules (Kurts et al., 1997; Rodriguez et al., 1999). This 
mechanism is referred to as ‘cross-presentation’. 
Specific antigen recognition is based on a tetramolecular complex of MHC molecule, 
presented peptide, TCR and one of its co-receptors, either CD4 or CD8. These co-receptors 
bind to nonpolymorphic regions of MHC molecules. They increase the avidity of a T cell to 
its cognate MHC/antigen-complex and they are also involved in intracellular signaling 
cascades. CD4+ T cells can only recognize antigen fragments bound to MHC class II 
molecules, whereas CD8+ and inflammatory T helper lymphocytes are restricted to peptides 
presented by class I molecules (Zinkernagel and Doherty, 1974, 1979, 1997). Recognition of 
MHC-peptide complexes results in different T cell effector functions: either killing of the 
infected cells (CD8 T cells, cytotoxic T helper cells) or enhancement of cellular and humoral 
responses (CD4 T cells). 
 
2.1.3 Dendritic Cells as Professional Antigen-presenters 
Dendritic cells play a key role in the immune system: They are the only antigen-presenting 
cells able to activate naive T cells to take part in primary immune responses and they can also 
stimulate secondary responses of memory cells (as do macrophages and B cells) so that they 
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 become effector cells. Thus, DC initiate adaptive immune responses and, depending on their 
maturation status, may also determine tolerance. 
Dendritic cells represent a heterogeneous population of cells. The majority of DC develops 
from myeloid stem cell precursors in the bone marrow (Steinmann et al., 1991; Inaba et al., 
1993) and resides at low numbers throughout all non-lymphatic tissues in a so-called 
‘immature’ state. Immature DC, e.g. Langerhans cells (LC) in the skin, retain large pools of 
MHC molecules intracellularly but express only few on the surface and are negative for co-
stimulatory molecules such as B7.1 and B7.2. Furthermore, they are characterized by their 
ability to take up and process pathogens and antigen (Romani et al., 1989) but having only 
limited capacity to stimulate naive T cells. DC sample their environment by constitutive 
micropinocytosis of extracellular fluid, and they also express different receptors mediating 
endocytosis and phagocytosis of pathogens and antigens. In response to inflammatory 
mediators (such as TNF-α, IL-1β), cytokines or necrotic cells, immature DC migrate to the 
T cell areas of secondary lymphoid tissues via afferent lymphatic vessels (Cumberbatch and 
Kimber, 1992; Cumberbatch et al., 1997). Here they undergo a switch from antigen capturing 
to antigen presenting and thus T cell-stimulating cells. This process, defined as DC 
maturation, includes assembly of MHC class I and class II complexes, up-regulation of co-
stimulatory molecules and secretion of cytokines. In addition, with maturation, DC rearrange 
their cytoskeleton and increase their mobility. They ‘convert’ to effective stimulators of naive 
as well as resting ‘memory’ T cells (Randolph et al., 1999).  
While immature DC very efficiently capture exogenous antigens and, upon maturation, load 
the antigenic peptides onto preformed empty and newly synthesized MHC class II molecules, 
mature DC shut off antigen capture and class II synthesis, and accumulate the newly formed 
complexes on the cell surface. The complexes acquire long half-lives – up to 100 hours in 
vitro –, allowing the DC to retain them for several days. Thereby presentation of antigens 
associated with infection is maximized. On the other hand, MHC class I-peptide complexes 
have much shorter half-lives (about 10 hours) and their presentation has to be sustained by 
continuous synthesis and loading (Lanzavecchia and Sallusto, 2000). 
DC are probably the most relevant source of IL-12, the major cytokine driving Th1 
polarization (see 2.2; Trinchieri, 1998). IL-12 production by DC is limited to a narrow time 
frame following stimulation and appears to be tightly regulated (Langenkamp et al., 2000). 
Thus, availability of IL-12 has to be maintained by a continuous immigration of recently 
activated DC. This mechanism allows the immune system to balance a Th1 response with a 
subsequent Th2 response even in case of the presence of pathogens strongly inducing IL-12. 
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 In addition, DC produce IL-18 and IFN-α, sometimes IL-4 and IL-10, which downregulates 
their own function as well as T cell responses. 
Mature DC have a finite life expectancy, affecting their capability to stimulate T cells. There 
is evidence that once they have reached the lymph node, they survive only a few days and 
disappear within 48 hours after interacting with antigen-specific T cells (Ingulli, 1997; Kurts, 
1996). 
Apart from the ‘classical’ myeloid-derived DC, a second type of DC can be found in thymus, 
spleen and lymph node: cells, which are derived from lymphoid precursors (Crowley et al., 
1989; Wu et al., 1991). In contrast to the myeloid lineage they express a CD8α-chain. Despite 
their phenotypic differences both populations behave similarly in processing and presenting 
antigens (Dalloul et al., 1999), but the outcome of T cell activation is different: while CD8α- 
dendritic cells preferentially induce Th2-type responses, CD8α+ cells induce responses of the 
Th1-type (Heufler et al. 1996; Stumbles et al., 1998). Recently it could be shown that the 
CD8+- but not the CD8- subset is involved in cross presentation (den Haan et al., 2000). 
 
2.1.4 T cell Activation 
For efficient activation of naive and resting T cells sole MHC-recognition alone is usually not 
sufficient and appropriate co-stimulation is required (2-signal model). MHC-peptide-T cell 
interactions have to be sustained and interactions of weak affinities have to be ‘supported’, 
i.e. enhanced. Compensation is carried out via additional co-stimulatory receptor/ligand 
molecules.  
Physiological T cell activation probably includes cytoskeletal polarization as well as large-
scale redistribution of cell surface molecules to give supramolecular activation clusters 
(SMACs; Monks et al., 1998). Thus, an organized contact interface is formed between T cell 
and APC. Because of many similarities with neuronal synapses, this cell-cell junction was 
coined immunological synapse (IS; Paul and Seder, 1994). While the duration of signaling is 
in the order of hours, the activating and inhibitory molecular interactions in the IS have half-
lives in the order of seconds. The mature synapse consists of a central cluster of T cell 
receptors surrounded by a ring of adhesion molecules (Monks et al., 1998). Its formation can 
be broken down into several steps (van der Merwe et al., 2000; Dustin and Chan, 2000; 
Dustin and Cooper, 2000): 
 
Polarization and attraction to potential APC by chemoattractants. A necessary factor in 
T cell activation is the encounter of a T cell with an antigen-presenting cell, such as a DC. 
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 Circulating T cells are triggered by chemokines (e.g. secondary lymphoid tissue chemokine) 
to pass through the high endothelial venules of blood vessels and enter the T cell areas of 
lymph nodes. At the same time, activated DC are also attracted to migrate from the tissue of 
infection to lymphatic organs where they are able to come in proximity and thus interact with 
many T cells. The initial reaction induced by a chemokine binding to its receptor includes the 
cytoskeletal reorganization of the T cell. This takes place even before the T cell makes contact 
with the APC and is a crucial preparation for antigen recognition (Dustin and Chan, review, 
2000). 
 
Non-antigen-specific adhesion. Adhesion requires an interaction of sufficient strength. The 
abundance of appropriate MHC-peptide complexes is too low, and their size too small (7 nm) 
to function as initial adhesion mediators. Therefore, adhesion molecules of some other kind 
are required. Several classes of such receptors appear to be important for T cell/APC 
interaction: the integrin family members LFA-1 (interacting with ICAM-1) and VLA-4 
(interacting with VCAM-1), and the smaller immunoglobulin superfamily molecules CD2 
(interacting with CD48), and CD28 (interacting with CD80 or CD86). They are larger 
(14-15 nm), abundantly present on T cells and form the so-called peripheral SMACs.  
The interaction of adhesion receptors with their ligands is of low affinity. It is therefore 
important to achieve an appropriate alignment of the apposing membranes to obtain a strong 
‘two-dimensional’ affinity (the physiological affinity of a given receptor as unit of surface 
density). An important aspect that should be mentioned is the fact that adhesion receptor 
affinity is regulated by TCR (Dustin and Springer, 1989). To date, this mechanism of positive 
feedback has not been fully understood. 
 
Engagement of TCR by MHC-peptide. At early time-points of synapse formation, junction 
formation includes engagement of MHC-peptide complexes in the outer ring, which are 
transported to the inner cluster area at later stages. 
TCR engagement is remarkably sensitive and flexible: Its affinities are in the range of 10-6M 
and it has half-lives in the range of seconds (for foreign peptide-MHC, Matsui et al, 1994). 
Very few foreign MHC-peptide complexes are necessary to trigger proliferation and synapse 
formation. It could be shown that full T cell activation correlated with synapse formation with 
a threshold density of ≥ 60 MHC-peptide complexes per square micrometer. Furthermore, 0.2 
molecules per square micrometer turned out to be the equivalent of 100-200 MHC-peptide 
complexes per APC, the minimum number of agonist complexes needed to provide sufficient 
stimulation for IL-2 production by T cells (Grakoui et al., 1999). 
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 Synapse formation. TCR/MHC-peptide engagement results in assembly of signaling 
complexes, generation of second messengers (e.g. Src-, Syk- and Tec-families of protein 
kinases) and induction of cytoskeletal changes. These include polymerization of actin at the 
interface of T cell and APC as well as reorientation of the microtubuli-organizing center 
(MTOC). Reorientation of the MTOC is an indicator for Golgi-apparatus-movement by which 
constitutive and regulated secretion are directed to the IS. Both, actin polymerization and 
MTOC reorientation are required to halt T cell migration. This is a critical factor for in vivo 
responses (Ingulli, 1997). Another molecule that is involved in the process of stopping 
migration is the co-receptor CD4 (Grakoui et al., 1999). 
TCR transportation from the initial site of engagement to the center of synapse is a 
remarkably active one, and may last up to 5-10 min until formation of the central SMAC 
(cSMAC) is complete. The central SMAC includes TCR/CD3, peptide-MHC, CD28/CD80, 
and cytoplasmatic signaling molecules (e.g. lck, fyn) and the synapse is now called mature. 
Interestingly, central cluster MHC-peptide complexes are not exchanged with free MHC-
peptide from the outside (photobleaching recovery experiments; Grakoui et al., 1999). 
The redistribution of cell-surface molecules has implicated two distinct transport processes: 
polarized secretion of cytoplasmatic storage vesicles, and redistribution of molecules already 
at the surface. 
 
Stabilization. Another critical parameter for T cell activation is the duration of signaling. 
Maintenance of IS over many hours may be promoted by molecular changes during 
maturation of the synapse. The localization of adhesion molecules may play a role in synapse 
stabilization: CD28/CD80 are frequently clustered in the center of the synapse, while 
CD2/CD48 often accumulate in outer rings. 
Alternatively, stabilization of the synapse could be promoted by the recruitment of so-called 
lipid rafts. Lipid rafts are microdomains in the plasmamembrane of T cells (and many other 
cells as well), which are rich in glycosphingolipids and cholesterol. Certain cell-surface 
molecules such as CD48 and CD4 are preferentially associated with these structures, while 
others, notably CD45, are not. Thus, lipid rafts provide a microenvironment in which 
signaling molecules necessary for T cell activation are readily clustered. Recent data describe 
the active reorganization of lipid rafts to the site of T cell activation. Binding of the associated 
molecules to ligands on an APC could provide a passive mechanism or the accumulation of 
rafts at the T cell/APC interface. Lipid rafts appear to play an important role in T cell 
triggering as their chemical disruption or mutations abrogate T cell activation. 
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 Repolarization (Termination). 
Cell-cell interaction has been described to occur between 24-48 hours in vivo (Ingulli, 1997). 
The organization of the synapse is a crucial factor determining the length of T cell/APC 
interaction: Poor organization results in spontaneous termination within a time frame of 
30 min. The T cell moves away from the site of interaction, and the cSMAC is degraded or 
shed. The T cell may now acquire a new polarity. 
 
2.2 Th1 and Th2: Subsets of CD4+ Helper Cells 
Activated CD4+ T lymphocytes can be classified into two distinct populations based on their 
cytokine profiles and on their effector functions: T helper 1 (Th1) and T helper 2 (Th2). This 
conveniently subdivides T cell immune responses into those specialized for defense against 
intracellular pathogens including viruses and some bacteria (Th1), and a second for defense 
against large extracellular pathogens such as helminths (Th2). Each subset produces cytokines 
that serve as autocrine growth and differentiation factors. The cytokine production of the two 
subsets also cross-regulates each other’s development and activity. Mosmann et al. (1986) 
were able to show that Th1 cells secrete IL-2, IFN-γ, TNF-α and TNF-β, cytokines, which are 
usually associated with inflammatory responses. IFN-γ induces the switching of 
B lymphocytes to certain IgG isotypes and activates macrophages enhancing their 
microbicidal actions. The principal function is to elicit phagocyte-mediated defense against 
infection. Some Th1 cells acquire cytolytic capacity. Both, IL-2 and IFN-γ promote the 
differentiation of CD8+ lymphocytes into active cytotoxic cells. On the other hand, the Th2 
subset produces cytokines such as IL-4, -5, -6, -10, and 13, with IL-4 being the major inducer 
of IgG1 and IgE responses, and IL-5 being the principal eosinophil-activating cytokine 
(Coffman et al., 1988).  
To date, it has not been possible to find a complete explanation for the stability of Th1/Th2 
populations, which, to a large extend, may be influenced by the conditions of initial priming. 
Apart from the cytokine patterns they secrete, their effector functions, and their activation 
requirements, the heterogeneity of Th subsets extends as well to their susceptibility to 
activation-induced cell death (AICD). Being a mechanism for peripheral depletion of CD4+ 
cells, AICD is implicated in the loss of effector cells, and thus in the termination of immune 
responses. Quite often an imbalance in Th1 and Th2 populations can be observed and Th1 
effectors are more susceptible to AICD than are Th2 effectors (Zhang et al., 1997). 
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 2.3 Development and Tolerance of T lymphocytes 
The immune system has to cope with the enormous variety of antigens its host may encounter 
during life. This difficulty is partly solved by the generation of a large repertoire of 
T lymphocytes, each bearing a different receptor. As the receptor diversity is generated by a 
mechanism that acts ‘randomly’ on the various gene segments, self-reactive antigen receptors 
are likely to be produced as well. How does the immune system tolerate the presence of these 
potentially destructive T cells? About half a century ago, Owen et al. (1946) were the first to 
discover that ‘tolerance’ of self-components is not inherited but acquired. Many genes that are 
involved in the regulation of the developmental stages have been identified, and it is now 
known that the T cells are ‘educated’ to distinguish self from non-self by two processes 
termed positive and negative selection. Together they result in a repertoire that is MHC-
restricted and almost fully tolerant to self, but the details of both mechanisms are still far from 
understood (Benoist et al., 1997; Marrack et al., 1997). 
 
Thymic ‘Education’ (Positive and Negative Selection) 
The developing T cell repertoire is shaped by two mechanisms taking place in the thymus: 
Positive selection of T cells describes a process that depends on the interaction of TCR with 
MHC molecules on cortical thymic epithelia, and is an essential step for differentiation of 
immature thymocytes into mature self-MHC-restricted cells. Negative selection ensures 
elimination of potentially autoaggressive T cells. According to the widely accepted model of 
affinity/avidity, an intermediate affinity/avidity of the TCR to the MHC is necessary for the 
immature thymocyte to be rescued from programmed cell death. Whereas no signaling results 
in death by neglect, cells with too strong affinity/avidity interactions are subject to apoptosis 
(Ashton-Rickardt et al., 1994; Nossal et al., 1994). Only those thymocytes with intermediate 
signaling strength are positively selected, and thus allowed to either continue maturation or 
become subject to negative selection. 
The thymus is made up of three physically distinct areas: an outer subcapsular zone, the 
cortex, and the medulla. Pre-T lymphocytes initially develop from bone marrow stem cells 
and then migrate to the subcapsular zone. When migrating into the cortex, they do not yet 
express the CD4 or CD8 co-receptor on the cell surface, and therefore are referred to as 
double negative (DN) thymocytes. In early DN thymocytes both TCR gene loci are still in 
germline configuration. In proliferating DN thymocytes, the TCR β-chain genes rearrange 
first. Upon successful completion, the β-chain assembles with the glycoprotein 33, an 
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 invariant partner chain also called pTα, to form a functional heterodimeric receptor (the pre-
TCR) which is then expressed on the cell surface together with the signal transducing CD3 
complex (Goettrup and von Boehmer, 1993). Expression of the pre-receptor not only triggers 
rapid proliferation and prevents further β-chain rearrangement; it also induces rearrangement 
of the α-chain locus and expression of CD4 and CD8 co-receptor molecules. The α-chain 
rearrangement violates the principle of allelic exclusion and may proceed through many 
cycles, possibly resulting in the expression of more than one TCR. CD4+CD8+ double positive 
cells (DP) are short-lived, and only those expressing TCRs that interact with cortical epithelial 
MHC-peptide complexes with a low but measurable avidity/affinity will be positively 
selected, i.e. rescued from undergoing apoptosis. Depending on the nature of the TCR-
peptide-MHC interaction, thymocytes are directed into the CD4+CD8- (MHC class II-
restricted) or into the CD4-CD8+ (MHC class I-restricted) lineage. 
Negative selection mainly takes place in the thymic medulla where it is mediated by dendritic 
cells. It ensures that any T cell that, at the time of maturation, is triggered to respond to 
intrathymically presented self-antigen above a certain signaling threshold will be removed by 
apoptosis (clonal deletion) or silenced by functional inactivation (anergy; Ramsdell et al., 
1989). An estimated one third of positively selected T cells are deleted during negative 
selection by bone-marrow-derived APC (van Meerwijk et al., 1997). Recent findings describe 
the expression of tissue-specific antigens in the thymus – a phenomenon termed ectopic or 
promiscuous gene expression, which appears to be a specific feature of the thymus (Hanahan, 
1998). The cellular and molecular regulation of such ‘promiscuous’ intrathymic expression is 
still poorly understood and has only recently been addressed by Klein et al. (2000) and 
Derbinski et al. (in press) who could show the intrathymic expression of several antigens is 
localized to medullary epithelial cells. The mechanism how self-tolerance induction through 
expression of tissue antigens in mTEC operates has yet to be unraveled. One possibility may 
be that it does not occur by T cell deletion but by generation and selection of regulatory 
T cells (Treg). It could be shown that the generation of antigen-specific CD4+CD25+ Treg cells 
appeared to be dependent on the expression of a neo-self antigen in radio-resistant T cells of 
the thymus (Jordan et al., 2001). 
Furthermore, MHC molecules may also shape the T cell repertoire postthymically, as these 
molecules seem necessary for the survival and homeostasis of naive cells in the peripheral 
lymphoid organs (Goldrath and Bevan, 1999). 
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 2.3.1 Peripheral Tolerance Induction 
Clonal deletion in the thymus is quite an efficient process, and results in a highly selected 
T cell repertoire. However, as some self-antigens are not permanently available or expressed 
in primary lymphoid organs but are expressed exclusively in certain tissues or at certain 
developmental stages, this process alone cannot be sufficient for full tolerance induction. 
While immature T cells are programmed to die when stimulated with high affinity/avidity, 
mature, peripheral T lymphocytes are ‘designed’ to respond by activation upon encountering 
their matching antigen. Once activated, reactive T lymphocytes may proliferate and be 
eliminated by a process referred to as clonal exhaustion. Such exhaustion of an immune 
response leads to the absence of immunological memory and is thought to result from 
permanent exposure to high antigen doses (Moskophides et al., 1993). 
Peripheral tolerance induction does not necessarily go along with physical elimination of 
T cells. Clonal anergy describes the ‘silencing’ of a certain auto-reactive subset of 
T lymphocytes, i.e. it is no longer able to respond to antigenic stimulation (Nossal et al., 
1994). These cells did not receive the second signal necessary for proliferation and 
differentiation. In some cases, a state of tolerance is reached by down-regulation of the TCR 
and co-stimulatory molecules (Rocha and von Boehmer, 1991; Schönrich et al., 1991; Ferber 
et al., 1994). 
Other mechanisms of peripheral tolerance induction consist of simple anatomic impediments: 
Homing receptors restricting T cells to secondary lymphoid tissues exclude recognition of 
most antigens expressed in non-lymphoid tissues. The expression of MHC class II molecules 
is restricted to antigen presenting cells, (Hämmerling and McDevitt, 1974; Hämmerling et al., 
1975) and is not found on non-lymphoid cells, thereby preventing activation of those CD4+ 
T cells gaining access to non-lymphoid areas. In immune-privileged regions such as brain, 
additional protection is provided by the blood-brain barrier that prevents lymphocytes from 
entering the central nervous system. In other organs such as gonads, placenta and eye, foreign 
antigen cannot initiate immune responses. This is partly due to their expression of 
immunosuppressive cytokines and cell surface ligands, e.g. the CD95-ligand (Fas-ligand), 
which results in killing of previously activated T cells that normally express Fas (Bellgrau et 
al., 1995; Mondino et al., 1996). The situation whereby potentially self-reactive T cells are 
separated from their cognate antigens by anatomic or functional (e.g. missing homing 
receptors) barriers is called clonal ignorance. 
After leaving the thymus, T cells re-circulate between the blood, lymph and secondary 
lymphoid organs. For activation and induction of immunity, certain requirements have to be 
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 fulfilled. Naive cells, i.e. all those never having encountered their cognate antigen in the 
periphery, leave the blood and enter lymph nodes using specialized molecules like selectins 
which are lost after activation and replaced by homing receptors for non-lymphoid tissues. In 
the T cell areas of lymph nodes or the marginal zone of the spleen, T lymphocytes may 
encounter antigen that has been either swept in passively from the surrounding tissue or 
presented by immigrated APC. The peripheral T cell pool is obviously tightly regulated in 
size (Rocha et al., 1995). This may be a result of competition for limiting niches such as 
availability of interdigitating DC in the T cell zones, or growth factors and cytokines 
necessary for proliferation and/or survival. In secondary lymphoid organs potentially auto-
aggressive T cells appear to be under control of a specialized lymphocyte population, the so-
called regulatory T cell subset. This mechanism is also referred to as active or dominant 
tolerance and can be transferred from one animal to another (Quin et al., 1993; Saoudi et al., 
1996). Furthermore, experimentally induced immune reactions could be suppressed by 
transfer of antigen-specific Th2 clones. In addition to the ‘classical’ pattern of interleukins, 
these regulatory T helper subsets secrete the transforming growth factor-β (TGF-β), an anti-
inflammatory and cell-growth inhibiting cytokine (Chen et al., 1994). Shifts from a Th1 type 
response to a Th2 have been termed immune deviation (Röcken and Shevach, 1996). 
Apart from these features, activation by microbial antigens is dependent on inflammation at 
the site of entry, that is the production of inflammatory mediators and cytokines by 
macrophages and parenchymal cells. Peripheral tolerance to regulated self-antigens (antigens 
that appear after a mature T cell repertoire has been formed) seems to be induced as an 
abortive form of T cell activation, which is a consequence of the absence of an inflammatory 
environment (Mondino et al., 1996). 
Another possibility to tolerize T cells in the periphery has been under recent discussion and 
involves a subset of CD4+ T cells, namely T regulatory cells. To date it is not clear whether 
CD4+ regulatory T cells are a homogeneous population able to perform several different 
mechanisms of suppression or whether it can be divided into subsets, each specialized and 
phenotypically as well as functionally distinct. A population of Treg was described that is 
constitutively present as a non-proliferative CD4+CD25+ subpopulation in lymph nodes and 
spleen of mice (Thornton et al., 1998), and that is able to suppress T cell responses 
independent of cytokines in a direct T cell contact-dependent fashion. On the other hand the 
existence of a CD4+CD25+CD45RBlow T cell population was reported that could be expanded 
in vitro with IL-10 and secrets immunosuppressive cytokines such as IL-10 and/or TGF-β 
(Groux et al., 1997).  
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 3 The Acute Phase and C-reactive Protein 
3.1 The Acute Phase 
The acute phase response refers to the global response of the body to the invasion of foreign 
agents after injury, infection or trauma. The aim is to prevent any further damage, deplete the 
infectious organisms and initiate wound healing. The acute phase includes drastic changes in 
the metabolic and biosynthetic profiles of many organs resulting in fever, the mobilization of 
neutrophils, an increased activation of B- and T lymphocytes as well as major shifts in the 
types of serum proteins synthesized by hepatocytes, especially of the so-called acute-phase 
proteins. All these effects result from the action of IL-1, IL-6 and TNF-α, cytokines released 
by activated macrophages (Baumann and Gauldie, 1994). 
 
3.2 Acute Phase Proteins 
Acute phase proteins (APP) such as the C-reactive protein (CRP) and serum amyloid P 
component (SAP) act as activators of the complement cascade and also as opsonins (Janeway 
and Travers, 2001). Unlike minor acute-phase proteins with basal levels that are elevated 2-5-
fold upon induction, the concentration of major acute-phase proteins may be increased up to 
1000-fold within a few hours (Steel and Whitehead, 1994). 
Hepatocytes are the main source of CRP production. Upon stimulation by bacterial 
lipopolysaccharide (LPS), monocytes and macrophages start secreting IL-1 and IL-6. These 
cytokines in turn induce CRP synthesis and secretion by hepatocytes (Mazlam and Hodgson, 
1994). 12 to 24 hours after the initial stimulus, CRP serum concentrations reach their 
maximum, thereafter declining to their basal levels by 72 to 96 hours. Usually only one APP 
functions as the major acute-phase reactant in a given species: In humans CRP is the major 
acute phase protein with a basal level of ≤1 µg/ml and a wide induction range (up to 
1000-fold), whereas in mice, only slight increases of mouse CRP (mCRP) can be observed 
during acute-phases. In mice, SAP is the inducible component while in humans SAP levels of 
30 µg/ml are expressed constitutively (Pepys et al., 1979; Steel and Whitehead, 1994). Within 
a species, the constitutive serum concentrations of some acute-phase proteins may vary 
significantly. In inbred mouse strains, the concentration of SAP in the absence of 
inflammatory stimuli differs very much and is genetically determined. Thus, the basal level in 
C57BL/6 mice is relatively low (5-10 µg/ml). 
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 CRP as well as SAP belongs to the pentraxin family of proteins. They are homologous in 
structure and in their function and bind to the phosphoryl choline (PC) portion of cell wall 
polysaccharides of certain bacteria and fungi as well as necrotic or apoptotic cells. It is 
involved in activating the classical complement cascade, which in turn induces direct lysis of 
the microorganisms. (Pepys and Baltz, 1983; Steel and Whitehead, 1994). Acute-phase 
proteins are highly conserved during evolution and appeared earlier than the 
immunoglobulins. Proteins with structural and functional homologies having been found in 
many mammals, fishes, and even in a species of crab (Limulus polyphemus, Sarikaputi et al., 
1991). High evolutionary conservation and the fact that to date no reports of individuals 
lacking hCRP have been described hint at an essential function of this protein. Apart from its 
ability to bind to the ubiquitously present PC, it also binds to the nuclear components 
chromatin, histones, small nuclear ribonucleoprotein (DuClos et al., 1988; DuClos, 1989; 
Volanakis et al., 1990) and to the extracellular matrix proteins fibronectin and laminin (Tseng 
et al., 1989). Only recently it has been shown that CRP binds to FcγR (Stein et al., 2000).  
By binding material derived from necrotic cells, hCRP may prevent autoimmunity to nuclear 
antigens (Steel and Whitehead, 1994). In addition, a role in tumor defense by the activation of 
macrophages and monocytes has been discussed (Barna et al., 1994). 
 
4 Aim of the Thesis 
Understanding the requirements for T cell activation is one of the fundamental issues in basic 
immunology as well as regards the design of immune-based therapies. 
Successful induction of an adaptive immune response depends on an appropriate antigen 
dose, duration of antigen presentation and the cellular environment in which antigen is 
presented. These parameters may vary according to the particular epitope recognized by T- or 
B cells. The in situ analysis of clonal or polyclonal T cell populations during the immune 
response has only recently become amenable to precise experimental analysis. Clusters of 
proliferating T lymphocytes have been shown to localize in proximity to dendritic cells 
(Ingulli et al., 1997), which are the MHC class II-expressing APC detectable in T cell areas of 
lymph nodes. Immigrated T cells interact with these DC and thus appear clustered. Several in 
vitro and in vivo studies initiated an ongoing debate about the duration, localization, dynamics 
and frequency of T cell/DC interactions required for full T cell activation. 
Here, a new approach is introduced to address the question of early T cell activation with 
respect to localization and time. We have been able to isolate T cell/APC clusters directly ex 
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 vivo from non-immunized and immunized animals by adopting and modifying a method 
previously described by Kyewski et al. (1986). We have defined these clusters as functional in 
situ units and compared the time and localization of T cell activation in different experimental 
models including both, CD4+ and CD8+ T cell as well as different MHC backgrounds. This 
approach for the first time provides a ‘bridge’ between existing in vivo and in vitro 
experiments. 
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Materials and Methods 
Materials 
1 Chemicals 
If not stated otherwise, the chemicals were obtained from Sigma, Deisenhofen. 
 
2 Buffer and Media 
2.1 Buffer and Media for Molecular Biology 
If not stated otherwise, Millipore water was used and the buffer and media were autoclaved. 
 
TE: 10 mM Tris-HCl; 1mM EDTA, pH 7.5 
 
TAE 1x: 40 mM Tris/acetate pH 7.5, 1mM EDTA 
 
Loading buffer 10x: 50% (v/v) glycerol (Roth GmbH, Karlsruhe); 10% (v/v) SDS (BioRad 
Laboratories, Hercules, USA); 0.5% (v/v) bromophenol blue; 0.5% (v/v) xylene cyanol; 
0.1 M EDTA (Fluka Chemie AG, Buchs, Switzerland) 
 
2.2 Buffer and Media for Cell Biology 
RPMI 1640 or Iscove’s (media and additives were obtained from Life Technologies, 
Eggenstein), supplemented with 5-10% (v/v) FCS (BiochromKG, Karlsruhe), HEPES 10 mM 
(pH 7.3), L-glutamine 2 mM, β-mercaptoethanol 50 µM, streptomycin 50 µg/ml and 
penicillin 50 U/ml. Fetal calf serum (FCS) was heat-inactivated at 56°C for one hour. 
 
Freezing buffer: 40% RPMI; 20% DMSO (dimethylsulfoxide); 40% FCS 
 
PBS (phosphate buffered saline) 10x, pH 7.2-7.4: 8 g/l NaCl; 200 mg/l KCl; 1.470 g/l 
Na2HPO4x2H2O; 200 mg/l KH2PO4 
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 3 Oligonucleotides (Primers) 
All primers were synthesized in the central division of the DKFZ (laboratory Dr. W. Weinig). 
The following oligonucleotides (sequences were obtained from c-DNA) were used for the 
genomic amplification of the β-chain of the Sep-tg T cell receptor by PCR: 
 
β-chain rearrangement: 
Vβ8.3 officially named BV8S3 (Arden et al., 1995), Dβ (Siu et al., 1984) and Jβ1.6 
(Gascoigne et al., 1984): 
 
5’primer: TCK 3  5’-GCA-TAC-TCG-AGT-CGC-GAG-ATG-GGC-TCC-3’ 
3’primer: LK 4  5’-CCA-AGA-CCG-CGG-TCA-TCC-AAC-ACA-G-3’ 
 
 
For PCR amplification of the variable regions of the Dep-tg T cell receptor α-chain the 
following primers were used: 
 
5’primer: LK1  5’-GAG-GAT-CCC-GGG-GAT-TGG-ACA-GGG-GCC-3’ 
3’primer: LK2  5’-CAG-GCG-GCC-GCA-TTG-TTC-TTC-CAA-AAT-AC-3’ 
 
4 Proteins and Peptides 
4.1 hCRP 
Human CRP was obtained from Sigma, Deisenhofen or one of our collaborators, Prof. Dr. 
MB Pepys, Royal Hospital, London, UK. The protein was purified from sera of patients 
showing inflammatory reactions. Highly purified hCRP (99.5%) was used for immunizing 
mice whereas proliferation experiments and restimulation experiments were carried out with 
hCRP of 95% purity. 
 
4.2 OVA 
Chicken ovalbumin grade 5-6 was obtained from Sigma and diluted from a stock solution 
concentrated at 10 mg/ml DMSO. 
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 4.3 Peptides 
Peptides were synthesized in the core facility for peptide synthesis at the DKFZ. The peptides 
include the subdominant epitope region A (peptide 81-92) and dominant epitope region B 
(peptide 89-100) of hCRP. The core regions of the peptides do not overlap. Furthermore, no 
reactivity for the gap region could be found (Döffinger et al., 1997). The peptides were 
dissolved in DMSO at a concentration of 10 mg/ml (stock solution). 
For stimulation of OVA-specific T cells either complete OVA or OVA-peptide 257-264 
(SIINFEKL) or the weak agonist SIINFEDL (variant D7, Jameson et al., 1993) were used. 
The peptides were dissolved in DMSO at a concentration of 10 mg/ml (stock solution). 
 
5 Antibodies 
Antigen Clone Species/Isotype Conjugate Reference/Source 
 
BrdU 3D4 mouse PE BD Pharmingen 
CD3ε 500A3 hamster, IgG biotin Havran et al., 1987 
CD4 H129.9 rat, IgG2b biotin, PE, Red 613 Gibco 
CD4 H129.19 rat, IgG2a FITC, CyChrome BD Pharmingen 
CD8 53-6.7 rat, IgG2a FITC, PE, Red 613 Gibco 
CD11c HL3 hamster, IgG PE BD Pharmingen 
CD25 PC61 rat, IgG1 PE BD Pharmingen 
CD44 IM7 rat, IgG2a PE BD Pharmingen 
CD45RB 16A rat, IgG2a PE BD Pharmingen 
CD62L Mel-14 rat, IgG2a PE BD Pharmingen 
CD69 H1.2F3 hamster IgG PE BD Pharmingen 
TCR Vα11 RR8-1 rat, IgG2b supernatant Jameson et al., 1991 
TCR Vβ5.1,5.2 MR 9-4 mouse, IgG1 biotin, FITC BD Pharmingen 
TCR Vβ8.3 1B3.3 hamster, IgG FITC BD Pharmingen 
 
Secondary Reagents for FACScan Analysis 
Biotinylated antibodies were detected with streptavidin-FITC (Boehringer), streptavidin-PE 
(Pharmingen), streptavidin-Red 613 (Gibco) or streptavidin-Cy-3 (self). 
 
Magnetic beads 
For magnet-activated cell sorting (MACS), anti-B220-, anti-CD8-, anti-CD11c- and 
streptavidin-beads (Miltenyi, Bergisch Gladbach) were used. 
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 6 Animals 
6.1 Wildtype strains 
Mice of the inbred strains C57BL/6 (H-2b) and Balb/c (H-2d) were obtained from Charles 
River WIGA (Sulzfeld) and kept under specific pathogen-free (SPF) conditions in the DKFZ 
animal house. 
 
6.2 TCR Transgenic Mice 
6.2.1 hCRP 
Transgenic mice expressing T cell receptors specific for either of two epitopes of the human 
C-reactive protein were generated in co-operation with Prof. U. Rüther, Hannover (Klein, 
1997). The transgenic TCR specific for the subdominant epitope expresses a Vα4/β8.3 
combination; the one recognizing the dominant epitope carries a Vα11/β5.1.combination. 
T cells expressing the transgenic receptor differentiate into CD4 positive cells, while CD8 
positive cells additionally make use of an endogenous α-chain. Positive selection of 
transgenic CD4+ lymphocytes is very efficient, with more than 80% of the peripheral 
population carrying the transgenic TCR with physiological density. 
 
6.2.2 OVA 
OT-I (CD8) and OT-II (CD4) TCR transgenic mice recognizing the dominant OVA epitope 
SIINFEKL have been described previously (Hogquist et al., 1994; Barnden et al., 1998). Both 
were bred on the C57BL/6 background for more than 10 generations. OT-I mice were kindly 
provided by Dr. Andreas Limmer, ZMBH, OT-II animals were obtained from Dr. Manfred 
Lutz, Erlangen. 
DO11.10 mice, which recognize the dominant OVA peptide 323-339 in the context of H-2d, 
(Ingulli et al., 1997) were kindly provided by Dr. Schimpl, Würzburg. 
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 Methods 
7 Molecular Biology Methods 
7.1 Genotyping of Mice 
7.1.1 Determination of DNA Concentrations 
Material: 
Quartz cuvettes, Spectrophotometer (Amersham Pharmacia Biotec, Freiburg) 
 
To determine the concentration of DNA in a solution, the sample was diluted appropriately, 
and the photometric absorbances at 260 and 280 nm were then measured relative to a distilled 
water blank. The concentration of dsDNA (µg/µl) can be calculated using the standard 
formula  
c = A260 x 0.05 x N 
 
with 0.05 being the standard absorption coefficient for DNA and N the dilution factor. 
i.e. A260 of 1.0 results from a dsDNA solution of concentration 50 µg/µl 
Purity of DNA can be estimated by dividing A260 by A280. Values of 1.7-1.8 for DNA indicate 
good purity; lower ratios indicate the presence of protein. 
 
7.1.2 Polymerase Chain Reaction (PCR) 
Material: 
10x concentrated primers (2.5 µm each); 10x conc. dNTP mixture (dATP, dCTP, dGTP, dTTP); Taq 
polymerase, 10x buffer (100 mM TrisHCl, pH8.3, 500 mM KCl, 11mM MgCl2 (all: MBI Fermentas, 
Vilnius, Lithuania), mineral oil, RoboCycler40 Temperature Cycler (Stratagene, Heidelberg) 
 
The technique of amplifying DNA by polymerase chain reaction (PCR) was used to identify 
TCR transgenic offspring. The reactions were carried out in a small volume of 25 µl, mixing 
250 nM of each primer, 10x buffer, 200 µM dNTP mix, 1.1 mM MgCl2, 250 ng genomic 
DNA and 0.5 U Taq-polymerase, sealing with mineral oil. As PCR was very sensitive, 
contamination had to be strictly avoided by using freshly autoclaved water as well as pipette 
filter tips. Thirty cycles with the following parameters were carried out: denaturation of DNA 
(94°C, 90 s), primer annealing at optimum temperature (54°C, 90 s), and chain elongation for 
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 2 minutes at 72°C. The initial denaturation step was extended to 150 s to ensure strand 
separation the last cycle was followed by an elongation phase of 3 minutes to ensure that all 
primers had been fully extended. 10 µl of each sample was loaded onto an agarose gel. 
 
7.2 Gel Electrophoresis of Nucleic Acids 
Material: 
Agarose; ethidium bromide UltraPure (Gibco, BRL Life Technologies, Eggenstein); TAE-buffer; 
100 bp ladder (Gibco, BRL Life Technologies, Eggenstein); UV-Screen (Kodak Banda, Wiesloch), 
Sony Video Graphic Printer UP 860 CE 
 
PCR products (see MM 7.1.2) were checked in agarose gels (1.2% in TAE, stained with 
ethidium bromide in a final concentration of 0.03 µl/ml gel). Size fractionation was carried 
out in TAE-buffer at 70 V. DNA fragments could be visualized and documented by 
photography using UV light (254 nm). 
 
8 Immunological and Cell Biology Methods 
8.1 Cell culture 
8.1.1 Cultivation of Eukaryotic Cell Lines 
Passaging of cell occurs under sterile conditions in a laminar flow (The Baker Company Inc. 
Stanford, USA). Cells and cell lines were cultured in complete RPMI 1640 or Iscove’s (see 
MM 2.2) at 37°C, 7.5% CO2 and 96% humidity (Hereaus incubator). 
 
8.1.2 Freezing and Thawing of Cells 
Material: 
Freezing buffer; RPMI 1640, complete with 5% FCS; 2 ml cryovial tubes (Nalgene Cryoware 
Rotheras, Hereford, UK); Minifuge T (Heraeus, Hanau) 
 
Cells were prepared by resuspending them in freezing buffer (1x106-5x106 cells/500 µl) and 
immediately placing them at -70°C. DMSO diffuses into the cells, thus preventing the 
formation of crystals when freezing and therefore the destruction of the cell membrane. After 
1-2 days the cells were transferred to liquid nitrogen for permanent storage. 
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 When thawing cells, it was very important that the thawing time be minimized. Frozen vials 
were transferred to a water bath (37°C) and, when thawed, the cells were taken up in 10 ml of 
fresh RPMI 1640. After centrifuging for 5 minutes at 1200 rpm, the pellet was resuspended in 
medium. 
 
8.1.3 Determination of Cell Number and Viability 
Material: 
Trypan blue solution (0.16% (w/v) trypan blue (Boehringer Ingelheim Bioproducts, Heidelberg), 
0.90% (w/v) NaCl, 0.1% NaN3, filtered through 0.45 µm, stored at room temperature), Neubauer 
hemacytometer 
 
Staining cell populations with trypan blue provides a possibility of visually distinguishing 
between unstained viable and blue-stained dead cells. For cell counting, a sample is mixed 
with trypan blue staining solution at the desired dilution factor (usually 1:5) and viable cells 
were counted in 4 large corner squares of a Neubauer chamber. The cellular concentration 
was calculated using the following formula: 
 
cells/ml = average cell count per square x dilution factor x 104 
 
8.1.4 Preparation of Mouse Single Cell Suspensions from Organs 
Material: 
Centrifuge, Minifuge T (Heraeus), 30 or 60 µm nylon gauze (Eckert, Waldkirch) 
 
If not stated otherwise, methods were performed (with some modifications) according to 
Selected Methods in Cellular Immunology (Mishell and Shiigi, 1980). 
After removal of the organs they were kept on ice in Petri dishes containing PBS or Iscove’s 
(5-10% FCS). The spleen was gently teased with a forceps, preferably without breaking it into 
small fragments. Cell suspensions of lymph nodes were obtained by pressing the organs 
between the previously sterilized ends of two microscope glass slides, thymi were carefully 
fragmented with forceps and transferred into suspension by repeated resuspension with 
pipettes. The cells were passed through 60 µm nylon gauze to remove aggregates and debris, 
and were then washed twice with PBS (1200 rpm, 5 minutes). Suspensions needed for 
functional assays were to be handled under sterile conditions. 
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 The nucleated cell yield per normal spleen was 0.5-1x108, for mesenteric lymph nodes 
2-3x107 cells were obtained, the thymus of mice 6-16 weeks of age contained approximately 
1x108 cells. 
 
8.1.5 Purification of Peripheral Blood Lymphocytes 
Material: 
Heparin (Braun, 5000 I.U./ml), Ficoll Histopaque-1077 
 
Peripheral blood was used to detect populations of transferred TCR transgenic lymphocyte 
populations in hCRP transgenic or C57BL/6 mice. After warming the animals using red light, 
4-5 drops of blood were extracted from the tail vein, preventing it from clotting by adding 
heparin-buffer (200 µl PBS, 50 U heparin/ml blood, FCS 2%). Leukocytes were purified on a 
Ficoll gradient at 1200 rpm for 20 minutes (RT, no brake). Cells recovered from the 
interphase were washed twice with PBS before staining. Purified lymphocytes could now be 
treated as previously described (MM 2.7). 
 
8.1.6 Red Blood Cell Lysis 
Material: 
Lysis buffer (155 mM NH4Cl; 10 mM KHCO3; 100 mM EDTA) 
 
The cell suspension to be depleted of erythrocytes was pelleted and 1 ml of lysis buffer was 
added to the pellet. After 90 seconds cells were washed twice in 50 ml medium or PBS. 
 
8.1.7 Isolation of T cell/APC Clusters (Rosettes) 
Material: 
Collagenase/Dispase buffer [Dispase grade I 0,2 mg/ml (Boehringer Mannheim/Roche Diagnostic), 
collagenase grade IV 0,2 mg/ml (Interchem, München), DNaseI (50 µg/ml; ICN), Aprotinin 
(12 TIU/mg), RPMI 1640 supplemented with 2% FCS and 20 mM Hepes] 
 
Preparation of lymph node clusters was performed with modifications as described by 
Kyewski et al., 1986. In short, pooled lymph nodes were depleted of free cells by stirring 
gently for 3-5 minutes at RT. Fragments were collected and digested 3-5 times (10 minutes, 
27-37°C) with collagenase/dispase buffer. Clusters were enriched by sedimentation at unit 
gravity through FCS (2 times 10-45 minutes, 4°C). 
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 8.1.8 Separation of Lymphocytes by MACS (Depletion) 
Material: 
Mini MACS (magnetic cell separators), MACS separation columns (both Miltenyi Biotec GmbH, 
Bergisch Gladbach), MACS buffer (PBS supplemented with or without 5 mM EDTA and 0.5% BSA),  
 
CD4
+
 cells were enriched by Magnetic Activated Cell Sorting (MACS). Lymph node and 
spleen cell suspensions were obtained as previously described (see MM 8.1.4). Cells were 
washed, pelleted and 106 to 107 cells were incubated with a cocktail of anti-B220 Microbeads, 
anti-CD8-, anti-Mac-1-, and anti-P7/7 supernatant (20 µl each, 15 min, on ice). After 
washing, the pellet was resuspended in 80 µl buffer, 20 µl MACS goat-anti-rat IgG 
Microbeads were added (15 min, on ice). Separation was performed as described (magnetic 
cell separation with MiniMACS, Manual, Miltenyi). In short, washed and resuspended cells 
were passed over the column. The effluent was collected as positive fraction, after removal 
from the separator magnetically labeled cells were flushed out of the column (negative 
fraction). To determine the enrichment, a suspension sample taken prior to the separation, as 
well as aliquots of the positive and the negative fraction were stained for the respective 
surface antigens and analyzed by flow cytometry (see MM 8.3.1). 
T cell/DC clusters were enriched by labeling with azide-free antibody and sav-microbeads 
and subsequent passing over a column. In contrast to single-cell suspensions, the flow-
through rate had to be slowed down with the help of a three-way stopcock. To avoid 
dissociation of the clusters, the whole procedure had to be performed with extreme care and 
all equipment was kept chilled. Purity was analyzed by fluorescence microscopy. 
 
8.1.9 In vitro Proliferation Assays 
Material: 
96-microwell-plates, round-bottom (Costar, Cambridge, MA), 3H-methyl-thymidine (Amersham 
International, Little Chalfont, UK), HL-1 medium (BioWhittaker, Wakersville, Maryland, USA) 
Micro Cell Harvester (Scatron, Norway), glass fiber filters (LKB-Wallac, Turku, Finland), Betaplate 
Harvester 1205 (LKB-Wallac) 
 
Freshly prepared mesenteric lymph node cells were stimulated with titrated amounts of 
peptide at a concentration of 5-6x104 cells/well in 200 µl HL-medium, supplemented as 
previously described (MM 2.2), for 60 hours and 20 µCi/well 3H-methyl-thymidine 
(Amersham) was added for the last 12 hours. Cultures were performed as triplicates. They 
were harvested on glass fiber filters and the incorporation of radioactive thymidine was 
measured by liquid scintillation counting using a Betaplate Harvester (Wallac, Freiburg). 
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 8.2 Immunochemistry 
8.2.1 Preparation of Antibody Supernatants 
Material: 
24-well plates (Costar), 100 ml and 500 ml culture flasks (Falcon), 1500 ml spinner flasks, Hereaus 
incubator (Heraeus, Hanau); Sorvall-centrifuge H6000A 
 
Antibody secreting hybridomas were incubated with RPMI 1640 (complete, 5% FCS) until 
grown to an approximate density of 106 cells/ml. As the average doubling time of hybridomas 
is normally between 12 and 24 hours, they were sub-cultured and expanded every 2-4 days by 
splitting the suspension and transferring some of it to a larger culture flask and medium was 
replenished. Depending on growth, cells were transferred to spinner flasks containing 500 ml 
of RPMI 1640 (complete, 5% FCS) and were incubated at 37°C for another 2-3 weeks. 
Medium was added at regular intervals to yield a final volume of 1.5 liters/flask. The cells 
were depleted (Sorvall, 10 minutes at 4°C, 3000 rpm) and sodium azide was added to the 
supernatant in final concentration of 0.1%. The antibody could now be purified or supernatant 
was frozen at - 20°C. 
 
8.2.2 Purification of Antibodies 
Material: 
RC-5 Superspeed Refrigerated Centrifuge (Sorvall); Falcon tubes (Falcon); sterile filters, 5 µm, 
pyrogen free (Schleicher & Schuell, Dassel); 0.22 µm sterile filters (Millipore, Bedford, USA); protein 
G Sepharose column (Pharmacia, Freiburg); Amicon chamber (Minicon-B, Amicon, Danvers, USA)  
 
Purification of the antibody solution was performed by affinity chromatography over a 
protein G bead column. The enriched antibody preparation was passed through a protein G 
bead column. The column was washed twice with 200-300 ml citric acid pH 5.0 to remove 
impurities, was eluted with citric acid pH 2.8 and 1 ml fractions were collected in Eppendorf 
tubes containing 500 µl of 1 M Tris pH 8.0 to bring the pH back to neutral. The antibody-
containing fractions were identified by absorbance at 280 nm and positive fractions [OD280 
higher than 0.14 (0.1 mg/ml)] were pooled and then dialyzed against PBS containing 0.1% 
sodium azide for 1-2 days. Again, the protein concentration was measured and either sodium 
azide (0.1%) was added or the solution was sterily filtrated (mesh 0.22 µm). Finally, the 
antibody was concentrated to a concentration of ≥ 1 mg/ml (Amicon chamber). 
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 8.2.3 Biotinylation of Antibodies 
Material: 
Biotin-X-NHS (Calbiochem Bad Soden); dimethylformamide (freshly prepared, 1 mg/ml) 
 
Purified antibodies incubated with biotin-X-NHS (100 µg biotin-X-NHS dissolved in 
dimethylformamide/mg antibody) were rolled o/n at 4°C. Non-bound biotin was removed by 
dialysis against PBS. 
 
8.3 Immunofluorescence Analysis 
8.3.1 Analysis of Cells Using Flow Cytometry 
Material: 
TCR transgenic cells, polystyrol tubes (Greiner, Nürtingen), FACS buffer; PBS, 5% FCS, 0.1% (w/v) 
NaN3, FACScan (Beckton-Dickinson, Heidelberg) 
 
Expression of cell surface antigens was detected by FACS analysis. For staining, 1-5x106 
cells were incubated with the according antibodies for 10-15 minutes at 4°C. They were 
washed once in FACS-buffer and then resuspended in 150 µl FACS-buffer. For flow 
cytometric analysis, data of 10,000 stained cells were collected and analyzed with a FACScan 
and Cellquest research software (Becton Dickinson, Apple Macintosh). Non-lymphoid and 
dead cells as well as cell fractions could be excluded from data collection by appropriate 
forward- (cell size) and side scatter (granulation) gating. 
 
8.3.2 Intracellular Staining of T cells with the Viable Dye CFSE 
Material 
PBS/0.1% BSA, 5-, 6-diacetate-carboxyfluoresceinsuccinimidylester (CFSE, Molecular Probes, 
Oregon, USA) 
 
The cells to be intracellularly stained with CFSE were washed twice in PBS, and were then 
resuspended at 1-5x107 cells/ml. CFSE was added to a final concentration of 2-5 µM, and the 
suspension was incubated at 37°C for 10 minutes. The reaction was stopped by adding cold 
PBS/10%FCS. To remove dead cells and debris, cells were filtered through 30 µm nylon 
mesh (Nybolt, Waldkirch). A cell loss of up to 30% had to be expected. 
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 8.3.3 Intracellular Staining of T cells with the Viable Dye CMTMR 
Material 
PBS, CellTracker™Orange (CMTMR, Molecular Probes, Oregon, USA) 
 
The cells to be stained with CMTMR were washed twice in PBS, and were then resuspended 
at 1-5x107 cells/ml. CMTMR was added to a final concentration of 1 µM (at higher 
concentrations the dye may become toxic), and the suspension was incubated at 37°C for 
30 minutes. The reaction was stopped by adding cold PBS. The cells were incubated for 
another 30 minutes to allow all dye to be converted. The cells were washed twice. To remove 
dead cells and debris cells were filtered through 30 µm nylon mesh (Nybolt, Waldkirch). A 
cell loss of up to 30% had to be expected. 
 
8.3.4 BrdU Analysis of Cell Division 
Material:  
BrdU (Sigma, Deisenhofen), PE-conjugated anti-BrdU (Pharmingen), PBS, DNaseI (ICN), DNase I 
buffer (4.2mM MgCl2, 0.15 M NaCl, pH 5-7), 2% paraformaldehyde in PBS with 0.01% Tween-20 
 
For short-term labeling, mice were injected intraperitoneally (i.p.) for two days every 
12 hours with 60 µg BrdU/PBS per gram body weight. 
Cell surface staining could be performed as previously described (8.3.1). BrdU staining was 
performed with little modification as previously described (Tough and Sprent, 1994). After 
washing with 2 ml PBS, the pellet was resuspended in 0.5 ml ice cold PBS and 1.2 ml 95% 
EtOH were added drop-wise while gently vortexing (to prevent T cell clumping). The cells 
were incubated on ice for 30 minutes and were then washed with 2 ml PBS. They were fixed 
with 1 ml 2% paraformaldehyde/PBS/0.01% Tween for 30 minutes at room temperature. 
Washing with 2 ml PBS was followed by incubation with 0.5 ml DNase (100 Kunitz units/ml 
in DNase buffer) for 10 minutes at room temperature. They were again washed with 2 ml PBS 
and incubated with anti-BrdU mAb for 30-60 minutes at RT. To allow non-bound antibody to 
leave the cells, they were washed and incubated another 10 minutes with PBS at RT. 
 
8.3.5 Immunofluorescence Microscopy 
After fixation with 2% PFA and appropriate staining, confocal microscopy was performed 
with a Zeiss LSM410 (later replaced by model LSM510) with the help of Dr. Herbert Spring, 
normal analysis was performed with a Zeiss Axiophot and Axiovision 3.0 software. 
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 8.4 Animal Experimental Methods 
8.4.1 T cell Transfers 
For cell transfers, spleen and mesenteric lymph node cells of TCR transgenic mice were 
prepared (see MM 8.1.4) and pooled. After red blood cell lysis (see MM 8.1.6), cells were 
analyzed for the frequency of TCR-tg T lymphocytes by FACS analysis. 4-5x106 transgenic 
cells/mouse were resuspended in 100 µl PBS and adoptively transferred intravenously (i.v.) 
into C57BL/6 or Balb/c mice. 
Transfers were also performed with intracellularly stained cells. 
 
8.4.2 Immunization 
Material: 
Metofane (Janisen-Cilay), antigen, PBS, Complete Freund’s Adjuvant (CFA, Sigma, Deisenhofen) 
 
Mice were anaesthetized by inhalation of Metofane and immunized into the hind footpads 
with antigen/PBS in CFA, total volume 50 µl/foot. 
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Results 
1 Isolation ex vivo and Characterization of T cell/APC Clusters  
1.1 Isolation and Enrichment 
The method of preparing T cell/APC clusters from thymus has been previously described 
(Kyewski et al., 1987). Here, this method was modified to obtain such clusters from lymph 
nodes. In most cases draining lymph nodes from animals previously immunized with antigen 
in CFA or CFA alone were prepared. To facilitate access to the T cell areas during the 
following collagenase/dispase digests, the capsules were carefully torn open with two 
syringes. The tissue fragments were transferred to small tubes and covered with RPMI 
containing 5% FCS. The tube was placed in a heated water bath and stirred for three minutes 
at 27°C. During this step non-associated (‘free’) cells were washed out. The fraction was 
collected and used as control fraction, referred to as ‘free cells’. The remaining tissue was 
now covered with collagenase/dispase and four subsequent digests at increasing temperature 
were performed. Each fraction was collected and microscopically analyzed for the content of 
clusters. Appropriate fractions were pooled and passed through 60µm nylon gauze. Clusters 
were enriched by two subsequent FCS-gradients at unit gravity. This way, a purity of 1:1 to 
1:10 (clusters:free cells) could be obtained. Staining of the dendritic cell marker CD11c 
revealed that approximately 70% of the clusters contained a DC as central APC. The average 
number of T cells clustered around each APC was 10-20. 
 
Figure 1 T cell/DC-clusters. Clusters were prepared from the draining lymph nodes of CFA 
immunized animals as described, and DC were stained with anti-CD11c-PE. (a) phase contrast, (b) 
fluorescence. Magnification: 400-fold. 
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 1.2 Cluster Purification via MACS 
To further enrich DC-containing clusters, the method of magnetic cells sorting (MACS) was 
adopted and modified. Compared to single cell sorting, sorting of clusters turned out to be 
more difficult: First, as clusters are multicellular complexes, they are much heavier than 
single cells and the thus ‘extra’ weight of the T cells surrounding the central APC has to be 
compensated by sufficient staining with beads. Additionally, the interactions holding clusters 
together are rather sensitive to substances interfering with receptor mediated interactions, 
such as trypsin, azide or depletion of divalent cations. Therefore the MACS-beads had to be 
removed from their original, azide-containing buffer and taken up in PBS. This was done by 
loading them onto a MiniMACS column, washing twice with PBS and flushing them out 
without diluting them. The purified, concentrated beads were used to label freshly prepared 
clusters in a volume of 50-100 µl for 30 minutes. After washing, the clusters were loaded onto 
a column. To minimize the flow-through rate and thus provide more time for labeled cells to 
bind to the column, a three-way stopcock was used. Because of the size of multicellular 
T cell/APC complexes we were faced with the problem of removing successfully loaded 
clusters from the columns by applying pressure low enough not to destroy them. Instead of 
using normal Mini- or Midi-MACS columns, we chose columns designed for separating large 
cells such as megakaryocytes (see Miltenyi, Manual). After washing twice to deplete non-
bound cells, the column was removed from the magnet and the clusters flushed out by quickly 
pipetting PBS through the column. 
Even though this method principally worked and separation of multi-cellular aggregates could 
be shown for the first time, it turned out to be too tricky and time consuming to apply it 
routinely. 
 
 
Figure 2 MACS-enriched clusters. Here, enrichment of MHC class II-positive thymic clusters, 
which were used to set-up this method, is shown. (a) and (b) depict the MHC classIIneg/lo fraction of a 
thymic cluster preparation after MACS enrichment. In (c) and (d) the MHC class IIhigh fraction is 
shown. Magnification: 250-fold. 
 31
 1.3 Stable Cluster Formation Is Antigen-independent 
The formation of DC/T cell clusters did not appear to be strictly dependent on deliberate 
antigen administration as it was also possible to isolate them in low numbers from non-
activated lymph nodes (even though here we cannot exclude an ongoing host infections). 
Nevertheless it has to be pointed out that the yield of clusters obtained from immunized 
animals was higher and increased with time after immunization. Furthermore, in case of 
antigen application, the number of clusters containing high numbers of Ag-specific T cells 
also increased. While from the mesenteric lymph nodes of non-immunized animals an 
average number of 1.5x104 ± 0.2 (n = 3) clusters could be obtained, it increased 2-10fold 
when preparing T cell/APC aggregates from the draining lymph nodes (inguinal and 
poplietal) of mice immunized with antigen in CFA. Thus, it can be concluded that clusters 
also form in the absence of deliberate immunization but that their formation is strongly 
enhanced by the presence of an ongoing local immune response. 
 
2 T/APC Clusters as ‘Functional Units’ of T cell Activation in situ 
2.1 Cellular Composition 
In order to define the cellular composition of clusters, we examined the phenotype of cluster-
associated versus non-associated T cells. Table I summarizes the results.  
 
  CD4 CD8 ratio 
CD4:CD8 
B220 CD11c 
CFA free 23.5 ± 6.8 20.1 ± 7.0 1.2 ± 0.2:1 56.8 ± 13.3 1.4 ± 1.3 
 cld* 11.5 ± 2.6 10.2 ± 5.3 1.2 ± 0.4:1 69.6 ± 9.5 3.9 ± 2.5 
Dep free 14.6 ± 2.2 10.4 ± 2.0 1.2 ± 0.3:1 n.d.* n.d. 
 cld * 16.0 ± 3.0 4.4 ± 2.3 2.5 ± 0.4:1 n.d. n.d. 
Sep free 10.8 ± 4.4 10.7 ± 2.7 1.4 ± 0.5:1 n.d. n.d. 
 cld * 14.3 ± 2.5 3.3 ± 0.3 3.2 ± 1.2:1 n.d. n.d. 
OT-I free 18.4 ± 4.9 17.7 ± 5.2 1.1 ± 0.3:1 69.5 ± 5.7 1.4 ± 1.1 
 cld * 10.4 ± 2.4 18.7 ± 5.3 0.6 ± 0.3:1 65.7 ± 8.0 7.7 ± 6.6 
Table I Cluster composition. All values represent the mean percentage ± SD of 3-5 experiments 
with 3 or more time points assessed. Note changes of the CD4:CD8 ratio in the cluster-derived 
fraction compared to the non-associated one (highlighted in red). 
* cld = cluster-derived; n.d. = not determined 
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 CD4/CD8 T cells 
In draining lymph nodes taken from animals that had been immunized with CFA only, the 
CD4:CD8 ratio of free and cluster-derived cells was determined on days one to three after 
immunization. Among free cells, a ratio of (1.2 ± 0.2):1 indicated the presence of almost 
equal numbers of CD4+ and CD8+ T cells. Among cluster-derived cells a ratio of (1.2 ± 0.4):1 
could be determined. The average percentage of non-associated lymphocytes was 23.5 ± 6.8% 
CD4+ and 20.1 ± 7.0% CD8+ T cells. In cluster-derived fractions numbers were only half as 
high, with CD4+ cells taking up 11.5 ± 2.6% and CD8+ cells resembling 10.2 ± 5.3% of the 
lymphocyte population. In two out of three experiments an increasing number of T cells could 
be observed in APC association with time while T lymphocytes in the non-associated fraction 
decreased simultaneously. This accounted for both, CD4+ and CD8+. 
 
One model used to analyze the cellular cluster composition upon Ag/CFA immunization was 
initially set up in our laboratory to answer questions regarding tolerance induction towards an 
inducible soluble serum protein, namely the human C-reactive protein (hCRP; Klein et al., 
1998). It includes two T cell receptor (TCR) transgenic (tg) mouse strains recognizing either a 
dominant (Dep, aa 89-100) or a subdominant (Sep, aa 81-92) epitope on the H-2b background 
(Klein, 1997; Klein et al., 1998). Immunizing animals with a previously determined amount 
of hCRP allowed us to ‘localize’ the ongoing immune response to a limited number of lymph 
nodes and thus obtain enough clusters for analysis. 
When comparing the cellular composition of free cells versus cluster-derived ones in the 
lymph nodes of animals that had been immunized with Ag/CFA and had subsequently been 
transferred with antigen-specific T cells on day four after immunization, a segregation of the 
corresponding T cells into clusters could be observed. While the CD4:CD8 ratio among non-
associated lymphocytes remained constant at (1.2 ± 0.3):1 (Dep) and (1.4 ± 0.5):1 (Sep) over 
a time range from 16-40 hours after transfer, an increased average ratio of (2.5 ± 0.4):1 (Dep) 
respectively (3.2 ± 1.2):1 (Sep) in the cluster-derived fraction could be observed. In 
comparison to CD8+ cells associated CD4+ cells are enriched by a factor of 2. Interestingly, 
this shift did not result from an elevation of the relative numbers of CD4+ cells compared to 
the non-associated fraction [14.6 ± 2.2% vs. 16.0 ± 3% (Dep) and 10.8 ± 4.4% vs. 
14.3 ± 2.5% (Sep)] but from a decrease in the proportion of cluster-associated CD8+ T cells. 
 
In addition to the hCRP model we examined the cellular cluster composition in the OT-I 
model. OT-I mice have been described previously (Hogquist et al., 1994). In short, CD8+ 
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 OT-I tg T cells carry a Vα2Vβ5.1 TCR and recognize the chicken ovalbumin-derived peptide 
SIINFEKL (aa 257-264) in the context of H2b. Upon cluster preparation from mice previously 
immunized with OVA and transferred with OT-I cells, the CD4:CD8 ratio among non-
associated lymphocytes also remained unchanged at 1.1 ± 0.3:1 over a time range from 
13 60 hours after transfer. Here, in the cluster-derived fraction an average ratio of 0.6 ± 0.3:1 
could be observed. Thus, associated CD8+ cells are enriched by a factor of 2 in this MHC 
class I model. With 18.7 ± 5.3% the relative number of CD8+ cells in clusters is not elevated 
compared to the non-associated fraction (17.7 ± 5.2%) whereas the relative number of CD4+ 
cells in clusters is only half as high as in the non-associated population (18.4 ± 4.9 vs. 
10.4 ± 2.4). 
 
Thus, in both models the ‘relative preponderance’ of lineage-specific T cells in the cluster-
derived fraction versus the non-associated fraction is not due to a relative increase in number 
of lineage-specific cells themselves but to a reduction of lymphocytes of the opposite lineage. 
 
B cells 
Several groups have reported the existence of B cell/DC clustering (Tew et al., 1990; Dubois 
et al., 1997; Björck et al., 1997; de Vinuessa et al., 1999). This association does involve both 
interdigitating DC (IDC) and follicular DC (FDC). Dubois et al. (1997) could show clustering 
of CD40L-transfected B cells with IDC in vitro, while Björck et al. (1997) found human 
tonsillar IDC of the T cell area to co-localize with naive B cells in situ. On the other hand 
FDC exhibit DC morphology, but are restricted to the light zone of germinal centers and lack 
phagocytotic activity. Instead they trap and retain immune complexes on their cell surface for 
prolonged periods of time. Furthermore, they have been subjected to play a role in 
plasmablast survival.  
With an average of 56.8 ± 13.3% of non-associated and 69.6 ± 9.5% of cluster-derived cells, 
B cells made up a surprisingly large proportion of cells in CFA immunized animals. 
In the OT-I model, the proportion of B220+ lymphocytes was similar to that of CFA 
immunizations: with 69.5 ± 5.7% among free cells and 65.7 ± 8.0% among cluster-derived 
cells, the number of B cells in clusters and non-associated cells were equally high. As with 
our method we were not able to distinguish between clusters derived from T cell areas and 
follicles, it remains to be shown whether the B cells originate from follicles or T cell areas. 
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 Dendritic cells 
In mice immunized with CFA alone, the number of dendritic cells - determined by CD11c-
staining of non-associated and associated cell fractions - were found to make up a small 
proportion. Expectedly, the numbers of DC in the non-associated fraction were lower 
(1.4 ± 1.3%) than those in the cluster fraction (3.9 ± 2.5%). Similar data was obtained for the 
OT-I model: The fraction of non-associated cells contained 1.4 ± 1.1% DC and the fraction of 
cluster-derived 7.7 ± 6.6%. The numbers of dissociated cells agree well with the relative 
frequency of DC in intact clusters (approximately 10-20 lymphocytes per cluster). It should 
be noted that the high SD values result from the observation that at early time points the 
number of DC-positive clusters was high but rapidly decreased after onset of proliferation: In 
one experiment numbers steadily decreased from 18.3% at 13 hours after transfer to 3.5% at 
60 hours after transfer – a finding that coincides with other groups who showed that the 
number of DC rapidly declines after activation of lymphocytes (Ingulli et al., 1997). 
 
2.2 Segregation of Ag-specific T cells into Clusters 
As immunization resulted in a difference in the T cell composition of cluster-derived fractions 
versus non-associated ones, it was of interest whether Ag-specific T cells preferentially 
interacted with APC and whether their distribution was random or selective. To do so, mice 
were immunized with human C-reactive protein/CFA and four days later 5x106 antigen-
specific T cells were adoptively transferred, which had previously been labeled with the 
intracellular viable dye CFSE. At several time points after transfer, 24-48 hours, clusters were 
prepared as described and 100 CD11c+ clusters were assessed for the number of labeled 
T cells they contained. Figure 3a depicts one out of three experiments performed with T cells 
recognizing the subdominant epitope of hCRP. It could be observed that the proportion of 
clusters containing one or more CFSE-labeled T cells increased over time while the number 
of clusters containing no labeled lymphocytes decreased at the same time. At 36 hours after 
transfer, the proportion of clusters containing green cells was the highest and decreased 
thereafter. Obtaining clusters from mice transferred with T cells specific for the dominant 
epitope (Dep) revealed that here the proportion of clusters containing green cells was the 
highest at 30 hours after transfer and decreased thereafter (Figure 3b). In both cases, a large 
proportion of clusters did not contain any CFSE-labeled cells at all time points. The 
coexistence of clusters devoid of any transferred cells and clusters with more than three 
 35
 antigen-specific cells accounts for a segregation of Ag-specific T cells into clusters. 
Considering an average number of 10-20 T cells per cluster, 3 or more CFSE-stained 
T cells/cluster equals ≥20%. In comparison, only 5% of cells in the non-associated fraction 
are CFSE-positive at this time point. Hence, there is a 5-fold segregation of antigen-specific 
lymphocytes in individual T cell/APC clusters. 
 
 
Figure 3 Segregation of CFSE-stained T cells into individual APC clusters during 
proliferation. Mice were immunized with 50 µg hCRP/CFA and subsequently received 5x106 CFSE-
labeled Sep- or Dep-specific T cells. Clusters were fixed with 2% paraformaldehyde and analyzed by 
fluorescence microscopy. 100 clusters were scanned randomly and the number of CFSE-stained 
T cells/cluster was counted. For Sep one of three experiments is shown, for Dep the only one 
performed. Note that for Sep-specific T cells (a) the accumulation of donor cells in clusters was 
highest at 36 hours after transfer while for Dep-specific T cells (b) it was highest at 30 hours after 
transfer. 
 36
 2.3 Only Recent Immigrants Segregate into Clusters 
Defining the cellular composition of clusters, we could show that antigen-specific T cells 
segregate into clusters. This finding led us to the question of whether APC-associated and 
non-associated lymphocytes differed in their functional status. We first assessed expression of 
the homing receptor CD62L, which is down-regulated upon lymph node entry through high 
endothelial venules. 
Clusters obtained from the draining lymph nodes of animals that had been immunized and 
subsequently transferred with Ag-specific lymphocytes were subjected to a short EDTA 
treatment to obtain a single-cell suspension for FACS analysis. Antigen-specific 
T lymphocytes were identified by staining the transgenic TCR β-chain as well as the 
corresponding co-receptor. Only cells having down-regulated CD62L were found in clusters 
while on non-associated T cells it was expressed at high levels (Figure 4, p38). This finding 
was confirmed in four different transgenic models (Dep, Sep, OT-II – all CD4 – and OT-I – 
CD8) as well as in animals immunized with CFA only and implies that only recent 
immigrants interact with antigen-bearing APC. 
 
2.4 Activation Status of Clustered T cells 
In addition to the homing marker CD62L we assessed the activation status of clustered T cells 
by staining of the IL-2 receptor β-chain (CD25) and the early activation marker CD69, which 
has been described to be up-regulated early after activation (2-6 hours; von Stipdonk et al., 
2001). Are T cells activated whilst in contact with their cognate APC or do they detach after 
receiving an appropriate stimulus and subsequently up-regulate activation markers? 
 
CD69 
Being one of the early events in T cell activation, the up-regulation of CD69 provided a 
means by which we could assess whether T cell activation is initiated while the lymphocyte is 
in contact with the APC or whether direct cell-cell contact is not necessary. Interestingly, 
strong CD69 up-regulation could be observed on cluster-derived, transgenic T cells only. This 
implicated that T cell/APC contact is a necessary parameter for activation (Figure 5a, p39). 
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 Figure 4 Segregation of CD62Llow T cells into clusters. Clusters were prepared at several time 
points after transfer. Cluster-derived and non-associated cells were analyzed by FACS for CD62L 
expression. Transferred cells were identified by expression of their transgenic TCR β-chain and the 
corresponding co-receptor. Data of 50,000 cells total were collected. 
 
CD25 
The supposition that T cell activation occurs concomitantly with APC contact was supported 
by the finding that in all four models investigated, CD25 was also found to be significantly 
up-regulated in the fraction of cluster-derived transgenic cells whereas associated non-
transgenic cells showed no or only little expression (Figure 5b, p39). Furthermore, 
lymphocytes that were non-associated did not up-regulate this marker significantly. 
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Figure 5 CD69 and CD25 are up-regulated on cluster-derived T cells only. Clusters were 
prepared at several time points after transfer. Cluster-derived and non-associated cells were analyzed 
by FACS for CD69 (a) or CD25 (b) surface expression. Transferred cells were identified by 
expression of their transgenic TCR β-chain and the corresponding co-receptor. Data of 50,000 cells 
total were collected. Note starting point of naive cells before injection. 
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 2.5 T cell Proliferation is Initiated in T cell/DC Clusters 
So far we have shown the cellular composition of clusters as well as the phenotype of both 
associated and non-associated T cells. The data obtained indicate that such aggregates could 
indeed be ‘functional units of T cell activation’ as has previously been proposed by several 
groups (Mitchison 1990; Ingulli et al., 1997; Kudo et al., 1997; Luther et al., 1997). We now 
wanted to address the question of whether T cells are not only activated in clusters but 
whether proliferation also is initiated in clusters. 
To dissect the proliferation kinetics of T cells specific for a dominant and a subdominant 
epitope of hCRP, T cell/APC clusters were prepared at different time points and analyzed for 
T cell proliferation. The use of the viable intracellular fluorescent green dye CFSE (5- and 6-
carboxyfluorescein diacetate succinimidyl ester), which segregates equally between daughter 
cells during division, allowed localizing the cells of interest ex vivo and determining their 
proliferation history. Again, C57BL/6 mice were immunized in both hind footpads. To allow 
for sufficient migration of antigen-loaded DC to the draining lymph nodes, a population of 
intracellularly stained Sep- or Dep-transgenic T cells was adoptively transferred four days 
after immunization.  
At 24 hours, both transferred populations could be detected in the lymph node in significant 
numbers but T cell division could not yet be observed (Figure 6, p41). Forward/side scatter 
analysis revealed that the onset of cell division already took place in the cluster-derived 
fraction. When being compared to free lymphocytes, cells dissociated from clusters contained 
an increased number of blasts, even though completed cell division could not yet be detected. 
For Dep-specific T cells, the first division, measured as CFSE fluorescence halving, could be 
observed at 30 hours in the cluster fraction but at this point not yet in the fraction of free 
lymphocytes (Figure 7, p42). Within the next 24 hours an increase in blasts occurred in both 
fractions and was accompanied by continuing cell division. Furthermore, at 36 hours after 
transfer the relative proportion of CFSE stained cells in the total population as well as in the 
blast fraction of dissociated lymphocytes was much higher than in the free ones and thus 
reflecting an enrichment of antigen-specific blasts within clusters. After 48 hours the 
population had divided four times, corresponding to an average division time of 4.5 hours. 
Now, the preponderance of blasts in clusters could not be found anymore and the relative 
proportion of CFSE-stained cells within the blast fraction was about twice as high in free cells 
as in the dissociated ones (24.9 ± 6.9% vs. 41.43 ± 9.2%). 72 hours after antigen encounter, 
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 the proportion of CFSE-stained cells within the blast population started to decrease in the 
fraction of dissociated cells but continued to increase in the fraction of free lymphocytes. 
 
 
Figure 6 Blast formation is initiated in T cell/APC association. Mice were immunized with 
50µg hCRP/CFA and subsequently received 5x106 CFSE-labeled Sep- or Dep-specific T cells. 
Clusters were prepared at the indicated time points after transfer. Cluster-derived and non-associated 
cells were subjected to FACS analysis. Data of 50,000 cells total were collected. Here, one exemplary 
experiment with Dep-specific T cells is shown. 
 
These results suggest an initial onset of proliferation while the T cells are still in contact with 
the APC, followed by an ‘APC-independent’ cell division. These findings are supported by 
the observation that the total number of clusters containing 3 or more CFSE-stained cells is 
highest during the early proliferation phase at the time of the first cell division and declines 
thereafter (Figure 3). 
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Figure 7 T cell proliferation is initiated in clusters. Mice were immunized with 50 µg 
hCRP/CFA and subsequently received 5x106 CFSE-labeled Sep- or Dep-specific T cells. Clusters 
were prepared at the indicated time points after transfer. Cluster-derived and non-associated cells were 
subjected to FACS analysis. Data of 100,000 cells total were collected. Note that cell proliferation is 
initiated in the APC-associated fraction and that there is an epitope-dependent shift in timing of the 
first cell division. Coloured lines depict the APC-associated fraction; in black the respective non-
associated cells. The analysis is restricted to large cells (“blasts”). 
 
Interestingly, even though T cells specific for a subdominant epitope of hCRP could also be 
localized in clusters at 24 hours, the first division of these cells lagged about 6 hours behind 
that of cells specific for the dominant epitope (Figure 7, red arrows). [In some experiments we 
could observe a very small proportion of cells undergoing cell division at 30 hours but here 
too, the majority of the T cell wave did not divide until 36 hours after transfer.] It should be 
pointed out that, – despite a later appearance of the first T cell division – Sep-specific T cells 
had also divided four times at 48 hours after transfer, amounting to an average division time 
of 3.5 hours. Apart from the 6-hour lag in the onset of proliferation, the same localization and 
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 proliferation pattern was observed for both epitopes. Notably, proliferation of Sep-tg cells is 
less vigorous but the t1/2 is shorter than that of lymphocytes specific for the dominant epitope, 
i.e. the average relative proportion of CFSE-labeled T cells found in the blast fraction was 
higher for Dep-tg cells than for Sep-tg ones [Dep: 41.4 ± 9.1% (free) versus 24.9 ± 6.9% 
(cluster-derived); Sep: 17.0 ± 3.2% (free) versus 14.0± 1.4% (cluster-derived)]. 
We wanted to further specify the onset of proliferation by analyzing first DNA replication. 
Would T cells specific for either the dominant or the subdominant epitope of hCRP be 
activated at the same time or would the delay in completion of the first cell division also be 
reflected in a delayed onset of transcription? For this approach we wanted to assess 
incorporation of bromodesoxyuridine (BrdU), a thymidine analogue. Unfortunately we could 
not obtain satisfactory results applying this method. Going through the procedure of cluster 
preparation and BrdU staining, which together took approximately 6 hours, appeared to be too 
stressful for the cells and FACS analysis was impossible to perform with the few cells left. 
 
Having defined the time interval required for T cell activation for two epitopes in the hCRP 
model we wanted to know whether this finding would also apply to CD4+ T cells of other 
specification. Thus we made use of the OVA/OT-II model, which also involves CD4+ T cells 
restricted to the IAb background as well as its H2d–restricted equivalent, the OVA/DO11.10 
model. Like hCRP-specific T cells, OVA-specific T lymphocytes could be detected within 
clusters at 24 hours after transfer in these two models as well (Figure 8, p44). Interestingly, 
completion of the first cell division was observed at 30 hours for both, OT-II- and DO11.10-
specific T cells – the same time it was completed in the Dep-specific population – and again it 
was more pronounced in the cluster-associated fraction than in non-associated cells. At 
48 hours cells of cluster-derived and non-associated fractions had undergone the same number 
of divisions and relative numbers of dividing cells were about equal [OT-II: 16.6% (free) 
versus 20.8% (cluster-derived); DO11.10: 6.9% (free) versus 8.3% (cluster-derived)]. This 
transition time mirrors the one observed in the hCRP model. These results indicate that the 
time frame and localization of T cell-activation of CD4+ T cells specific for different 
dominant epitopes appears to be a constant parameter. 
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Figure 8 T cell proliferation is initiated in clusters. Mice were immunized with 50 µg 
OVA/CFA and subsequently received 5x106 CFSE-labeled OT-II- or DO11.10-tg T cells. Clusters 
were prepared at the indicated time points after transfer. Cluster-derived and non-associated cells were 
subjected to FACS analysis. Data of 100,000 cells total were collected. Note that cell proliferation is 
initiated in the APC-associated fraction. Coloured lines depict the APC-associated fraction; in black 
the respective non-associated cells. The analysis is restricted to large cells (“blasts”). 
 
The overall patterns of early antigen-specific T cell activation in four different CD4 models 
including two different MHC backgrounds (H2b, H2d) being the same, we asked whether 
T cells of the CD8 lineage would behave similarly. With the OT-I model available, BL/6 mice 
were immunized with 50-100 µg SIINFEKL or complete OVA. Four days later, 4-5x106 
CFSE-labeled OT-I transgenic CD8+ T cells were adoptively transferred. At 24-48 hours after 
transfer T cell/APC clusters were prepared as described and analyzed for proliferation. 
Similar to the hCRP/Dep model, OT-I transgenic T cells had readily localized in clusters by 
24 hours after transfer (Figure 9, p45). At 30 hours, the first T cell division had taken place, 
again in the cluster-derived fraction only. Proliferation continued during the following 
18 hours but different to the CD4 models the percentage of CFSE-labeled cells in the cluster-
derived fractions was remained above that of the non-associated fraction. Thus, CD4+ and 
CD8+ T cells behaved similarly with regard to compartmentalization but the average transition 
time of CD8+ T cells apparently is longer. 
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Figure 9 Initiation of T cell proliferation is delayed for a weak agonist. Mice were 
immunized with 50 µg SIINFEKL or SIINFEDL/CFA and subsequently received 5x106 CFSE-labeled 
OT-I-tg T cells. Clusters were prepared at several time points after transfer. Cluster-derived and non-
associated cells were subjected to FACS analysis. Data of 100,000 cells total were collected. Note that 
cell proliferation is initiated in the APC-associated fraction and that there is an epitope-dependent shift 
in timing of the first cell division. Coloured lines depict the APC-associated fraction; in black the 
respective non-associated cells. The analysis includes small lymphocytes as well as blasts. 
 
Up to this point we could show that the onset of T cell proliferation in response to 
immunization turned indeed out to be a constant parameter: in models, in which lymphocytes 
responded to dominant epitopes, the first cell division had taken place 30 hours after transfer 
– irrespective of the T cell lineage or the MHC background. In the case of a subdominant 
epitope, a delay of roughly 6 hours could be observed. The OVA/OT-I model is well defined 
with regard to peptide derivatives: apart from the SIINFEKL peptide, which functions as a 
strong agonist, a number of weak agonists have been described (Jameson et al., 1993). Would 
a stimulus induced by such a weak agonist result in a proliferation history like that of the 
subdominant epitope or like that of dominant epitopes? Or would it result in a different 
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 outcome of the immune response? We chose the OVA peptide257-264 variant D7, which carries 
an aspartic acid instead of a lysine at position 7 and has been described to function as a weak 
agonist. 
Again OT-1 transgenic cells could be detected in clusters 24 hours after transfer (Figure 9, 
p45). In contrast to clusters prepared from control animals that had been immunized with 
SIINFEKL, proliferation of the majority of antigen-specific T cells could not be detected 
before 36 hours after transfer in SIINFEDL-immunized mice. Three interesting observations 
could be made: First, at 48 hours, the mean fluorescence of dividing cells in the blast fraction 
was higher than that of controls indicating that they had undergone fewer divisions. Second, 
the relative and absolute numbers of cells taking part in the response were lower. Third, while 
in all other models specific lymphocytes found in cluster-derived and non-associated fractions 
had undergone the same number of divisions at 48 hours, in the SIINFEDL model cells in the 
APC-associated populations had undergone at least one more division than those in the non-
associated one. Hence, a weak agonist delays the kinetics and reduces the extent of clonal 
expansion. 
 
2.6 Microscopic Analysis of Early T cell Proliferation 
While FACS analysis of CFSE dilution patterns allows determining the onset of proliferation 
as well as the time needed for each division with regard to the whole T cell population, 
microscopic analysis provides a means to directly correlate stages of T cell division to 
individual clusters as depicted in Figure 10 (p46). At 24 hours after transfer cells were still 
bright green and often small, even though blasts could already be detected. For Dep-specific 
lymphocytes, blast formation became more prominent at 30 hours, and first doublets could be 
observed. For Sep-specific T cells these stages appeared at 36 hours. With ongoing clonal 
expansion segregation was found within clusters and at 48 hours dim green dividing and small 
cells were also found cluster non-associated. At 72 hours most labeled cells had left clusters. 
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Figure 10 Microscopic analysis of early T cell proliferation. Different stages of T cell/APC 
interaction are depicted in (a). These interactions are shown schematically in order of their appearance 
over time for Dep- (b) and Sep-specific (c) T cells. Magnification: 400-fold, overview 250-fold. 
 
2.7 Proliferation Kinetics are Antigen Dose-independent 
What could the delayed onset of proliferation of T cells specific for the subdominant epitope 
be explained by? Can it possibly be attributed to distinct TCR affinities or to differential 
antigen-display? TCR affinities of both Sep- and Dep-specific T cell populations have not 
been precisely determined and therefore its correlation with delayed proliferation remains 
open. In in vitro experiments it was found that the T cell clone specific for the subdominant 
epitope (from which our TCR transgenic mice were generated) was more sensitive to 
stimulation than the Dep-specific one, i.e. lower peptide doses were required to reach 
equivalent levels of proliferation (Döffinger et al., 1997). On the other hand, presentation of 
the naturally processed dominant epitope has been shown to be 100-fold more efficient than 
that of the subdominant epitope (Klein et al., 1995). If lower peptide density was responsible 
for the delayed kinetics, a reduction in antigen dose should mimic such a situation. 
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 We wanted to know whether lowering the amount of antigen available during the antigen-
specific response would affect its outcome with regard to the onset, extent and duration of 
proliferation of the transferred cells. Mice were immunized with titrated amounts of hCRP. At 
several times after T cell transfer proliferation kinetics were performed (Figure 11). 
 
 
Figure 11 The T cell response to hCRP is sensitive to low antigen dose. Mice were immunized 
with titrated amounts of hCRP/CFA. Four days later 3-5x106 CFSE-labeled Dep- (a) or Sep-specific 
(b) T cells were adoptively transferred i.v. into the tail vein. Clusters were prepared at 24-48 hours 
after transfer, subjected to EDTA-treatment and assessed for CFSE halving patterns by FACS 
analysis. Data of 100,000 cells total were collected. Note that the extend of proliferation does not 
titrate; proliferation is, however, abolished when Ag-levels drop below a threshold of 0.1 µg/mouse. 
 
Titrating hCRP from 50µg/mouse down to 0.5µg/mouse did not affect the time point of 
completion of the first cell division of either population. However, at antigen doses of 
0.1µg/mouse or below proliferation could no longer be detected. Antigen-specific cells seem 
to temporarily accumulate in clusters, but do not receive stimulation strong enough to trigger 
T cell activation. Regarding the extent of proliferation also no dose-dependency could be 
observed. Proliferation of Sep-tg lymphocytes was always lower than that of Dep-tg ones. 
From these data we conclude that both T cell populations are highly sensitive to low antigen 
dose, whereas below a certain threshold of antigen available to APC no proliferation takes 
place. Above this threshold it appears not to matter how much antigen is applied: the outcome 
of the response does not alter. 
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 2.8 Average ‘Retention’ Time in Clusters 
Having defined T cell/APC clusters as functional units of initial T cell proliferation, the data 
obtained allows estimating the average ‘retention’ time of the T cell wave – the fate of 
individual cells cannot be determined with our method – in this compartment: The first T cells 
could be detected at 12-16 hours after transfer. After another 18-20 hours cluster-associated 
T cells had completed their first round of cell division, which then became independent of 
APC contact. Taking into consideration that at day 3-5 of an ongoing immune response 
highest numbers of antigen specific T cell are found in blood and spleen (data not shown), 
T cells are likely to be leaving the lymph node by 72 hours after transfer. Thus, the T cell 
wave needs approximately 32-36 hours to pass through the cluster ‘compartment’ from the 
time of first cell-cell interaction. 
 
Figure 12 Average retention times in the cluster compartment. All cells (small lymphocytes and 
blasts) were included in the analysis. For Dep, Sep and OT-I/SIINFEKL the means and standard 
deviations of three independent experiments with 2 mice per time point are shown, for 
OT I/SIINFEDL data of one experiment are plotted. Open symbols represent the non-associated, 
closed symbols the cluster-derived fractions. Note that large error bars at later time points result from 
a widely varying extent of proliferation. 
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 3 Concomitant Activation by two T cell Epitopes in situ 
 
To date only little is known on whether epitope hierarchy influences clonal expansion and 
whether two adoptively co-transferred clonal T cell populations, which are specific for 
epitopes of the same protein, influence each other (Busch et al., 1998). Is the response to the 
subdominant epitope enhanced by a simultaneously occurring response to the dominant 
epitope, e.g. due to up-regulation of MHC class II or co-stimulators on APC (Sercarz et al., 
1993)? Interleukins released by proliferating cells could create a local microenvironment, 
which facilitates the initiation of a response by cells directed towards subdominant epitopes 
that are located in the same cluster. Alternatively, the response could be suppressed because 
of competition for growth factors such as IL-2 or spatial limitations preventing the outgrowth 
of either population. This question could be important for the understanding of the etiology of 
autoimmune diseases, which is generally accompanied by the recognition of subdominant or 
cryptic self-epitopes, a process referred to as ‘epitope spreading’ (Sercarz, 1998; Yu et al., 
1996). 
Previous work addressing the question of a mutual influence of two T cell populations 
specific for different epitopes of the same protein included adoptive transfer experiments into 
antigen-expressing hosts (Hommel, 1998). In these mice, hCRP is abundantly present 
(500 µM) and thus does not reflect an immune response, where antigen usually is temporally 
limited. In this model, within 24 hours transferred transgenic cells recognizing either epitope 
had disappeared from the blood and migrated to all peripheral lymph nodes as well as the 
spleen. After encountering antigen, the numbers of both Sep- and Dep-tg lymphocytes 
increased drastically, with peak numbers in the blood generally being found 4 to 5 days after 
injection. Peak numbers of T cells specific for the subdominant epitope were lower than those 
of lymphocytes specific for the dominant one. Nevertheless, the expansion and contraction 
pattern of the ongoing response was the same. These results were consistent with those of 
Busch et al. (1998), namely that T cell populations specific for dominant and subdominant 
epitopes expand with a similar kinetics but the responses differ in their magnitude: while 
dominant epitopes elicit large responses, subdominant epitopes elicit smaller ones. When we 
co-transferred both populations, an expansion pattern similar to that obtained from the single 
transfers could be observed. This implies that in a model where antigen is abundantly present 
(i.e. where both epitopes are presumably presented above threshold) there is no or only minor 
interference between the populations. 
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 Limiting antigen availability would be expected to first result in a presentation below a 
critical threshold of the subdominant epitope while the dominant epitope would still be 
presented above. At such a dose the response should be most sensitive to the effects of 
intramolecular help. We therefore replaced the above transfer model by a ‘more 
physiological’ one to determine whether the two T cell populations behave similar or different 
under limiting antigen availability. In contrast to experiments performed by Busch et al., 
adoptive transfers in the hCRP model have the advantage that defined T cell populations can 
be followed. 
 
3.1 Transient Antigen Supply 
Non-transgenic C57BL/6 animals were injected i.v. with 4-5x106 transgenic T cells of either 
specificity or a mixture of both. This way it was possible to follow a pre-existing T cell 
population without overloading the system with T cells of one specificity. One day later 
1-100 µg hCRP were applied intravenously to examine the course of the ongoing response not 
only in a time- but also in a dose-dependent fashion. If distributed equally in the whole body, 
the amount of 100 µg protein corresponds to approximately half of the basal concentrations of 
protein in the extracellular space found in hCRP-tg males that had been used in the transfer 
experiments described above. Since hCRP resources were limited, the injection of higher 
doses had to be renounced. The extent of T cell expansion was evaluated four days after 
antigen application by FACS analysis as the percentage of T cells carrying the transgenic Vß+ 
chain within the CD4+ population of the lymph node. Results are shown in Figure 13a+b 
(p52). 
Upon single transfer both populations revealed a dose-dependent extend of proliferation. 
While cells specific for the dominant epitope (Dep) reached a value of 25% at the highest 
protein concentration and the titration curve was still increasing, cells specific for the 
subdominant epitope (Sep) made up only 10% of the lymphoid CD4 compartment and the 
expansion appeared to have almost reached the plateau phase. These results implicate that 
under antigen-limiting conditions dominant epitopes elicit larger responses than subdominant 
epitopes in this model. 
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Figure 13 Dose response of Sep- and Dep-TCR-tg T cells upon single and co-transfer. Mice 
were adoptively transferred with 2x106 Dep- or Sep-specific T cells or a mixture of both. One day 
later, titrated amounts of hCRP in PBS were injected i.v. into the tail vein. After four days mesenteric 
lymph nodes were harvested and analyzed for specific T cell proliferation. Data of 10,000 cells were 
collected. The results shown represent the means and standard deviation of three independent 
experiments, each including three mice. Note that both the response to the dominant and the 
subdominant epitope is altered upon co-transfer. 
 
3.2 Altered Responses Upon Co-transfer 
When both populations were co-transferred, the number of T lymphocytes responding to Sep 
was elevated for all hCRP concentrations (15% at 100µg hCRP). Also the shape of the curve 
of Dep-specific expansion reflected a pattern different to that of the single transfer: at low 
antigen concentrations there was a stronger response, but at high protein concentrations it now 
was significantly lower (Figure 13). 
 
Taken together, these results document the phenomenon of ‘intramolecular help’ (Sercarz et 
al., 1993), which describes the dependency of one T cell population on another with respect to 
the threshold of activation. Thus, in the case of limiting hCRP availability this would mean 
that the proliferation capacity of T cells specific for the subdominant epitope is augmented by 
the simultaneously occurring response to the dominant epitope. 
 
3.3 T cells of Different Specificity Co-localize in the Same Clusters 
A necessary prerequisite for intramolecular help would be the co-localization of both 
populations in the same cluster. When antigen and T cells are injected i.v., the latter dilute too 
much to prepare clusters containing Ag-specific cells in numbers sufficient for analysis. Thus, 
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 to ‘localize’ both T cell populations to the same APC, C57BL/6 mice were immunized in both 
hind footpads and a mixture of intracellularly labeled (CFSE and CMTMR) Sep- and Dep-
specific T cells was adoptively transferred four days later. After two days, T cell/dendritic cell 
clusters were prepared from draining lymph nodes. Confocal microscopy allowed visualizing 
the co-localization of T cells specific for both epitopes. 
 
Figure 14 Co-localization of Dep- and Sep-specific T cells in T cell/APC clusters. Clusters were 
prepared at 48 hours after T cell transfer, fixed with 2% paraformaldehyde and stained for MHC class 
II-expression (red). Co-localization of Sep- (blue, CMTMR-labeled) and Dep-specific T cells (green, 
CFSE-labeled) was analyzed by confocal microscopy. 
 
Cluster  Sep Dep Total No. of 
cells/cluster 
Doublets 
1 1 3 7 - 
2 - 2 9 1* 
3 2 2 5 1* 
4 2 1 5 - 
5 1 2 5 1* 
6 - 2 5 1* 
Table II Quantification of clusters containing transgenic T lymphocytes on day two after 
T cell transfer. Here, one exemplary experiment is shown. Note: To facilitate determination of 
labeled cells, only small clusters (≤15 cells) were included in the analysis. * Dep-tg only 
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 Quantification of clusters containing fluorescent T cells (Table II) revealed that many of the 
cells taking part in cluster formation were of a transgenic phenotype. It could be shown that 
both cell types associated in the same clusters. Therefore, the pre-requisite for intramolecular 
help was given. 
 
3.4 Prolonged Antigen Supply 
To investigate whether there would be mutual influence upon co-transfer of both, Sep- and 
Dep-specific T cells, under limiting but prolonged antigen supply both populations were 
transferred simultaneously to Ag/CFA immunized C57BL/6 animals. As CFA acts as a depot 
antigen is released slowly. It therefore is available longer than upon i.v. injection but still 
temporarily limiting. Because no second intracellular dye with properties similar to those of 
CFSE was available, only one population could be labeled at a time. When clusters from co-
transfers were prepared at different time points, no difference in the onset of proliferation 
could be observed (Figure 15). Only at 36 hours the extent of proliferation was a little higher 
in the single transfer controls. 
 
 
Figure 15 Upon co-transfer under transient but prolonged antigen availability T cells specific 
for the subdominant epitope behave as in single transfers. 5x106 CFSE-labeled Sep-specific T cells 
alone (controls, dark blue) or a mixture of 5x106 labeled Sep- and 5x106 unlabeled Dep-specific T cells 
(light blue) were adoptively transferred to hCRP-immunized mice. Clusters were prepared at the 
indicated times, and proliferation of Sep-specific T cells was analyzed. Data of 100,000 events were 
collected. 
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Discussion 
Successful induction of an immune response is not only determined by how ‘foreign’ the 
antigen is to the host, but also by the context in which it is presented, by its dose and by the 
duration of its presentation (Zinkernagel et a., 1997). These parameters may vary according to 
cellular environments in which an antigen is presented and the particular epitope recognized 
by T- or B cells. Clonal proliferation is an essential feature of the adaptive immune response. 
In vivo studies using T cell receptor transgenic models have provided new insight into this 
particular issue (Kearney et al., 1994; Ingulli et al., 1997). 
Here, a novel methodological approach was introduced: We were able to isolate T cell/APC 
clusters directly from lymph nodes ex vivo and define them as functional units of T cell 
activation. Furthermore, labeled populations of T cells could be followed on their transit 
through this lymphoid microenvironment and it was possible to define several stages of the 
early proliferation phase. Thus, for the first time, we provide data bridging existing in vivo 
and in vitro studies. Several important findings could be made: First, it was shown that only 
recent immigrants segregate into such clusters. Second, the onset of proliferation was found to 
take place while the lymphocyte is in contact with an APC. Third, for dominant epitopes the 
time of completion of the first T cell division was determined to be a remarkably invariant 
parameter in different models, while T cells specific for a subdominant epitope and a weak 
agonist lagged behind in the onset of cell division. Fourth, in all models assessed the early 
APC-dependent proliferation phase was followed by an independent one and the average 
transition time for T cell populations specific for different antigens through the cluster 
compartment ranged between 32-36 hours from the time of first contact. Fifth, T cells specific 
for different epitopes of the same protein could be co-localized to the same APC. 
 
Mitchison (1990) was the first to propose a role of multicellular T cell/DC clusters in 
mediating T helper activity and it has meanwhile been shown in situ that clusters of 
proliferating T cells are found in proximity of DC in T cell zones of secondary lymphoid 
organs after injection of superantigens (Luther et al., 1997) or allogenic cells (Kudo et al., 
1997) and in an adoptive transfer model (Ingulli et al., 1997). Do the clusters isolated and 
described here represent the ex vivo correlate of the cell aggregations observed in the intact 
tissue in vivo? This contention is supported by the results described in this study and by 
previously published observations: 
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 The group of Jenkins and colleagues adoptively transferred fluorescent dye-labeled, antigen-
loaded DC and naive TCR transgenic CD4+ cells specific for an OVA/H2d complex and used 
confocal microscopy to track their in vivo location. In lymph node sections they observed that 
OVA-specific T cells formed clusters around paracortical DC that were pulsed in vitro with 
antigen (Ingulli et al., 1997). In accordance with observations in these sections our aggregates 
were small, with approximately 10-20 cells clustered around each APC. Compared to 
untreated animals, we observed a 2-5-fold increase in numbers after immunization, thereby 
documenting a positive correlation between the occurrence of clusters and an ongoing 
immune response.  Previous studies on multicellular clusters from the thymus, which are most 
likely analogous to those analyzed here, implied that the composition in vivo of thymus-
derived lymphostromal cell interactions was retained during preparation and enrichment: 
When clusters were isolated from in vitro mixtures of thymuses of homozygous Thy1.1- and 
1.2-congenic mice, T cells strictly segregated into individual aggregates according to their 
phenotype and clusters retained their phenotype during further enrichment. Furthermore, in 
chimeras containing varying proportions of Thy1.1 and 1.2 T cells, thymocytes of either 
phenotype segregated non-randomly into individual clusters (Kyewski et al., 1982). 
Interestingly, when analyzing lymph node-derived aggregates, associated cells uniformly 
displayed low levels of CD62L as opposed to non-associated lymphocytes – irrespective of 
specific immunization. The CD62L molecule is the peripheral lymph node homing receptor 
used by naive circulating lymphocytes to enter lymph nodes via high endothelial venules 
(HEVs). Upon binding to its addressins and transmigration, CD62L is transiently down-
regulated. Our observation not only suggests that cluster-associated lymphocytes represent 
recent immigrants, but also implies non-random cluster composition. 
Selective composition is also reflected by the segregation of antigen-specific T lymphocytes 
into such aggregates: While at the time of first T cell division the overall proportion of 
transferred T cells was about 5%, a 4-fold enrichment of antigen-specific lymphocytes in 
individual T cell/APC clusters (> 3 cells/10-20) could be observed. At the same time the 
majority of clusters was devoid of any transferred T cells. Given this non-random distribution, 
it is highly unlikely that cluster formation occurs secondary to digestion and isolation. What 
could account for this conspicuous segregation? One possible explanation is the limitation of 
antigen-loaded APC. If this was true in our approach, immigrating T cells would have to 
‘search’ for their specific APC. To date only little is known about the distribution of antigen-
loaded DC within the paracortical region of the lymph node but in one report APC bearing a 
particular antigen appeared to be scarcely distributed within the T cell areas of the lymph 
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 node (Inaba et al., 1998). Considering the mode of immunization as well as the dose 
dependency of this response, a limitation of antigen-bearing DC is unlikely to occur in the 
study presented here. Alternatively, antigen-loaded APC are not limiting, but those APC 
strategically localized at the entry site of T cells are preferentially seeded. A third possibility 
is that antigen-specific lymphocytes are limiting and therefore seed only few APC whereas 
other antigen-loaded APC remain empty. At present we cannot distinguish between these 
alternatives. In any case, segregation could either be the result of multiple independent 
seedings of an individual APC or of clonal expansion within a cluster. The observed sequence 
of events within a cluster – attachment of single small lymphocytes followed by blast 
formation and doublets – is in favour of the second alternative. 
 
T cell/APC interaction is a necessary prerequisite for T cell activation, but to date little is 
known about the in situ localization of T lymphocytes at the early stages of proliferation. By 
using different transgenic transfer models and isolating clusters at various time points after 
T cell transfer it was possible to analyze this aspect: 12-16 hours after transfer the first T cells 
could be detected in the draining lymph nodes and started clustering around APC. Cell 
division was then initiated 18-20 hours later, while the T cells were still associated with DC. 
This early APC-dependent proliferation phase was followed by an APC-independent 
proliferation at later stages. The time needed for the ‘T cell wave’ from the initial APC 
contact to pass through the cluster ‘compartment’ was approximately 32-36 hours. It is 
important to note that the transition time was essentially constant for both T cell lineages 
(CD4 and CD8), in different transgenic models (hCRP, OVA) and on different MHC 
backgrounds (H2b, H2d). This time frame and the localization of T cell activation – as 
summarized in Figure 16 (p58) – agree well with the observations of Ingulli et al. (1997). 
They found that in their model transgenic OVA-specific CD4+ T cells and Ag-pulsed DC 
accumulated to maximum level in the T cell areas of lymph node and spleen within one day 
of i.v. injection. The accumulation of T cell/DC clusters then slightly declined by 48 hours. 
Despite the disappearance of DC in the paracortical region, a dramatic increase of T cells in 
this area was found to take place during the following two days. Thus a DC-dependent phase 
was followed by a DC independent one. Furthermore, the group was able to correlate DC-
T cell interaction with activation by staining for the production of IL-2.  
The distinction of an APC-dependent versus APC-independent phase of the immune response 
has been recently addressed in several studies. Analyzing the activation requirements of naive 
CD4 T cells the group of Susan Swain concluded from their in vitro experiments that ‘the 
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 optimum effector generation depends on an initial two days of TCR stimulation followed by 
an additional two days of Ag-independent, cytokine-driven T cell expansion and 
differentiation’ (Jelley-Gibbs et al., 2000). They also determined efficient antigen 
presentation to naive and effector T cells by professional APC to be in the range of two days. 
These in vitro data are well in line with our in vivo results. Indeed, the concept that CD4+ 
T cells become activated in an Ag- and cell-cell contact-dependent fashion in the first two 
days of an adaptive immune response, which is then followed by an Ag-independent one, can 
possibly be extended to a third phase: proliferation of activated lymphocytes in the blood. 
Vasseur et al. (1999) assessed the distribution of cycling T lymphocytes in blood and 
lymphoid organs during the immune response to different antigens and found that the 
accumulation of Ag-specific T cells in the lymphoid compartment is only transient (1-2 days), 
with proliferating cells rapidly recirculating to the blood after activation. This also is in 
concordance with our finding that numbers of Ag-specific T lymphocytes in the lymph node 
start to decrease after two days. 
 
 
Figure 16 Schematic overview of T cell activation. Cellular events are shown above the time axis, 
and the time needed by each model to complete the first cell division below. 
 
Two other groups addressed this issue for the CD8 T cell lineage. Van Stipdonk et al. (2001) 
as well as Kaech and Ahmed (2001) show that a ‘brief’ encounter with antigen is sufficient 
for naive CD8+ cytotoxic T cells to start a ‘program of proliferation and differentiation’, 
independent of any further contact with antigen-bearing APC. Van Stipdonk et al. used 
engineered APC – a fibroblast cell line expressing the costimulatory molecule B7.1 and 
presenting a modified OVA peptide on MHC class I – and OT-I transgenic T cells to assess 
the degree to which the proliferation of naive cytotoxic T lymphocytes (CTL) depends on 
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 activation stimuli. T cells were incubated with plate-bound APC and removed from these 
culture conditions at various time points to be placed in new, antigen-free cultures. As little as 
two hours of T cell/APC interaction turned out to be sufficient to fully commit the CTLs and 
drive them through several rounds of division. Kaech and Ahmed used a more sophisticated 
approach in that they combined in vitro and in vivo assays: naive CD8+ T cells, which had 
been stimulated in vitro for 24 hours, were purified, intracellularly labeled with CFSE and 
transferred into normal BL/6 mice to monitor the proliferation and differentiation in the 
absence of antigen in vivo. Remarkably these cells underwent more than eight divisions, 
acquired full effector function and gave rise to memory cells.  
Both studies confirm our finding that in the CD8+ system, too, an early APC-dependent 
activation phase is followed by APC independent proliferation, while the time needed to 
complete the first cell division widely differs between the in vitro approach (van Stipdonk et 
al, 2001) and our in vivo data. Possible reasons for this difference shall be discussed 
elsewhere. 
 
The finding that T cell activation is initiated in cell-cell contact comprises another important 
issue: the time needed by T cells from initial APC contact to proceed through their first 
division. Recognition of dominant epitopes resulted in completion of this first division by 
30 hours after transfer, a surprisingly invariant parameter – independent of different model 
antigens (hCRP or OVA) or the MHC background (H2b, H2d). This observed lag of 
18-20 hours from the initial T cell/APC contact to completion of the first round of cell 
division coincides with in vivo results from Gudmundsdottir et al. (1999) and in vitro data 
obtained by Jelley-Gibbs et al. (2001). Importantly, using an approach similar to ours – 
adoptive transfer of CFSE-labeled Ag-specific T cells and subsequent immunization – 
Gudmundsottir et al. could show that in the OVA/ DO11.10 TCR-tg model T cell 
proliferation was initiated at approximately 30 hours after immunization. When analyzing 
CFSE-dilution profiles of cell cultures, Jelley-Gibbs et al. observed that in their model naive 
CD4+ T cells displayed a delay of 24 hours between initial TCR stimulation and the onset of 
proliferation. Furthermore, Iezzi et al. (1998) used influenza hemagglutinin (HA) specific 
T cells recognizing peptide 100-119 in the context of I-Ed in in vitro assays under varying 
stimulatory culture conditions. From the data obtained the minimum contact time between 
TCR and surface bound peptide/MHC complexes for naive T cells to become committed to 
proliferation was determined to be in the range of approximately 20 hours. This minimum 
duration of interaction required for activation of naive T cells could be lowered to 6 hours 
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 when mature DC were functioning as APC (Lanzavecchia et al., 1999). From these results in 
conjunction with our data, it can be proposed that proliferation of naive CD4+ T cells is 
preceded by a prolonged phase of cell-cell contact and possibly TCR triggering. 
In contrast, our observation of CD8+ T lymphocytes also showing about 24 hours of APC 
contact before onset of proliferation is challenged by the in vitro data of van Stipdonk et al. 
(2001). 2 hours of interaction, as proposed in their model, appear to be strikingly short. In this 
context the work of Gunzer et al. (2000) should be delineated, who published an analysis on 
the duration, dynamics and frequency of T cell/DC interactions in an artificial extracellular 
collagen matrix: Using video microscopy, the group observed that T cell/DC clusters were 
small and T cells maintained vigorous movement upon interaction with cognate DC. The 
duration of T cell/APC interactions was short and transient (3-20 minutes for individual 
contacts) and resulted in a sequential sum of 2 hours total per 24 hours. When taking away the 
collagen matrix and keeping the cells in liquid culture only, an antigen-independent formation 
of large stable cell aggregates could be observed. Furthermore, proliferation in liquid culture 
turned out to be 4-fold more efficient than in the extracellular matrix. Thus, it is most likely 
that the short antigen-dependent phase found by von Stipdonk et al. could at least partially be 
accounted for by their experimental set-up, i.e. different stimulating conditions such as 
antigen density, T cell to APC ratio or stable aggregate formation. 
To date we are unable to distinguish between prolonged or transient T cell/APC interactions 
during the observation period with our methodological approach, and Gunzer’s findings do 
not necessarily contradict ours. On the other hand, in the matrix model T cell contacts to DC 
were shown to be both, specific and nonspecific and the presence of antigen did not alter the 
median interaction times as compared to antigen-independent interactions. This is in contrast 
to data implying that T cell activation is initiated in clusters and thus requires prolonged and 
stable cell-cell contacts, which occur as formation of the immunological synapse (Grakoui et 
al., 1999). Even though the clusters described in this study represent only a snap shot, the fact 
that they remain intact during isolation and enrichment requires cell-cell interactions of 
sufficient strength – as could be provided via stable and long-lasting synapse formation. 
The requirements for successful T cell triggering entails the apparent paradox that 
MHC/complexes are of low affinity but nonetheless have to provide sustained cell-cell 
contact. Two models are presently tempting to reconcile available data on this issue: 
According to the single encounter model infrequent encounters between T lymphocytes and 
APC are stabilized by an adhesive mechanism to allow prolonged TCR triggering. 
Alternatively, the serial encounter model favours that effective T cell signaling is not a 
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 continuous process, but acquired by repeated TCR engagement. T cells respond to the density 
of MHC-peptide complexes on several antigen-loaded DC but do not respond if the outcome 
of additive interactions remains below a certain threshold (reviewed in Lanzavecchia and 
Sallusto, 2001). Which model can our observations best be accommodated with?  
The lymph node provides a microenvironment that differs from that of in vitro experiments 
using suspension culture or extracellular matrices: First, completely different from randomly 
arranged fibers of extracellular collagen matrices generated in vitro, lymph nodes have a 
much denser structure and contain larger numbers of cells. Second, the T cell area of resting 
lymph nodes (the so-called ‘corridors’ in the cortex) provides a cellular environment with the 
abundant collagen fibers being ‘packed away’ in stromal cells forming the reticular network 
and thus providing only little or no possibility of T cell-collagen contacts. The corridors are 
densely packed with cells and thus provide an ideal predisposition to foster cell-cell 
interactions between local APC and migrating T cells (Gretz et al., 1997). Interdigitating DC 
are the predominant APC in this area (Steinman, 1991). Even though they constitute only a 
small proportion of the overall cellularity of a lymph node (approximately 2%), their shape 
provides a large surface for contact as they become immobilized and line the fibroblastic 
reticular cells of the corridor space. After passing through this collagen-rich space, T cells 
enter the collagen-free parenchyma. Third, even though migrating T cells continuously follow 
chemokine gradients, the key chemokine receptors necessary for migration, such as SLC, are 
likely to be desensitized upon entry through HEVs (Ebnet et al., 1996). Thus, due to its 
‘micro-architecture’ the lymph node represents an environment, which should favour 
prolonged rather than transient cell-cell interactions. 
Apart from the appropriate microenvironment, extended T cell/APC interaction – as probably 
reflected in the delay from initial T cell/APC contact to the onset of proliferation observed in 
our models – would also require a certain stability of MHC-peptide complexes. If their half-
life (t1/2) was short (in the range of minutes to few hours) and they were lost from the cell 
surface quickly, this would abrogate cell-cell contact. Interestingly, the t1/2 of MHC-peptide 
complexes was found to be dependent on the microenvironment and the APC subtype but 
independent of the combination of MHC and peptide. Thus, it appears to be an invariant 
parameter that is determined by the turnover of MHC-peptide complexes on the cell surface 
and not by the turnover of APC themselves (Röttinger, 2000). For Langerhans cells and 
immature APC of the spleen a t1/2 of between four to six hours could be determined while in 
non-activated mesenteric lymph nodes they ranged from seven to ten hours. Moreover, the 
ability to present MHC-antigen complexes to T cells could be strongly improved upon 
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 combined antigen-CFA application: CFA induces the maturation of DC and therefore 
increases the proportion of mature DC in the draining lymph nodes. With maturation they lose 
their ability of efficient antigen-uptake and processing but convert to very effective antigen 
presenters (Guèry et al., 1997). When antigen was applied in combination with CFA, the t1/2 of 
MHC-peptide complexes presented on the cell-surface increased by a factor of 3-6 to more 
than 30 hours. This t1/2 of MHC-peptide of 30 hours on mature DC would provide for 
prolonged antigen availability for activation and is concordant with the mean interaction time 
of T cells with APC in vivo. 
Hence, both the lymphatic microenvironment as well as the prolonged t1/2 of MHC-peptide 
complexes are more easily reconciled with the single encounter model. 
 
Interestingly, even though in all models analyzed transferred T cells could be localized in 
clusters at the same time, the onset of proliferation of T lymphocytes specific for a 
subdominant epitope in the hCRP model and that of T cells responding to a weak agonist in 
the OVA/OT-I TCR-tg model lagged behind that of cells specific for the corresponding 
dominant epitopes. Additionally, T cells specific for both, the dominant and subdominant 
epitope of hCRP, had undergone equal numbers of divisions at 48 hours after transfer – 
despite the delayed onset of proliferation of Sep- specific lymphocytes. How can these 
findings be explained? Two possible explanations have to be considered: lower epitope 
density and, alternatively, distinct TCR affinities. Epitope dominance is defined as more 
efficient presentation compared to subdominant or cryptic epitopes. In the hCRP model 
antigen-presentation of the naturally processed subdominant epitope is 100-fold weaker than 
of the dominant one (Klein et al., 1995). Dominance of one epitope versus subdominance of 
the other may be due to different mechanisms (Döffinger et al., 1997): First, the processing of 
hCRP may take place in a manner protecting the dominant epitope while preferentially 
degrading the subdominant one. Second, the dominant epitope may bind much stronger to IAb 
and thus prevents a more efficient presentation of the subdominant epitope. Third, 
immunodominance could be the result of quantitative and qualitative differences in the T cell 
repertoire. The possibility of a higher T cell precursor frequency specific for the dominant 
epitope can be excluded in the experiments presented here as equal numbers of transgenic 
T cells were transferred. If the dominant epitope was presented more efficiently than the 
subdominant one, this could account for an earlier onset of proliferation of T lymphocytes 
specific for the dominant epitope, whereas a higher affinity of T cells specific for the 
subdominant epitope could be an explanation for increased proliferative activity. 
 62
 If the lag in the onset of T cells specific for a subdominant epitope can most likely be 
attributed to its lower presentation, what could account for that of a weak agonist? Weak or 
partial agonists are variants of antigenic MHC-peptide ligands that have altered capabilities to 
induce T cell responses. The ability of MHC-peptide complexes to exhibit biological activity 
correlates with their binding affinity for the TCR and weak agonists have a faster off rate than 
full agonists (Germain and Stefanova, 1999; Jameson and Bevan, 1995). The attempt to 
explain the influence of small differences in off rates of the TCR on the time required by 
T cells to become committed to activation resulted in two models (reviewed in Germain and 
Stefanova, 1999): the kinetic proofreading and the kinetic discrimination models. Both predict 
that ligands with fast off rates permit very transient TCR interaction only, thereby inducing 
very early but not late activation events. This way, the minimum time required to complete 
formation of a fully competent signaling complex would enable the TCR to discriminate 
between high and low-affinity ligands. An approach to link this discrimination to defined 
intracellular events was recently published by Rosette et al. (2001). They assessed the OT-I 
T cell response towards a low- versus a high affinity TCR ligand with regard to differences in 
early and late activation events. Using conventional APC or tetrameric forms of the antigen, 
the authors could show that the differences in T cell activation by either OVAp or its weak 
agonist variant G4 were not due to the steady-state occupancy of the TCR but rather to kinetic 
parameters such as the duration of TCR/MHC-peptide interaction. Furthermore the kinetics of 
the T cell response did not correlate with alternative activation pathways. Both OVAp and G4 
were able to induce maximal CD69 up-regulation in vitro, but 1000- to 10000-fold higher 
doses of G4 were required to reach equivalent responses. The expression of CD69 was similar 
at 24 hours but up-regulation in response to G4 was found to lag at least 5 hours behind that 
of OVAp. CFSE dilution assays also revealed a similar lag in the proliferative response. 
These in vitro results are in perfect concordance with our in vivo observation. Based on their 
findings, the authors proposed a revised model of kinetic proofreading in which activation by 
low-affinity ligands leads to full responsiveness by ‘trickling through to less reversible 
downstream signaling intermediates’. A possible candidate to act as a ‘counter’ for productive 
TCR/ligand engagements is phosphorylated c-Jun, which was shown to slowly accumulate 
over time. 
 
To place our findings in the context of current models on the dynamics of T cell activation, a 
revised version is proposed: If – upon recognition of a weak agonist – individual TCR/ligand 
interactions are more transient than those with strong agonists, prolonged signaling will be 
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 required to accumulate a critical number of effective intracellular ‘counts’ and result in a 
positive signal. This can be achieved by either of two possibilities: increasing the absolute 
number of interactions or extending the individual interaction time. Including the serial 
encounter model in these considerations, an increase in the number of interactions can result 
from more numerous individual TCR/MHC-peptide contacts on the same APC but also from 
multiple (serial) encounters with different APC. It therefore is possible that accumulation of 
intracellular ‘counters’ above a critical threshold induces a ‘stop’ signal, allowing for a stable 
and prolonged cell-cell contact in form of the immunological synapse. This in turn elicits late 
activation events and the lymphocyte can proceed through cell cycle. In the case of 
subdominants epitopes one would predict that to accumulate enough positive counts the 
number of interactions also has to be increased – not because of more transient interactions 
compared to dominant epitopes but because of lower epitope density. Hence a longer 
interaction time would be required. This way both, serial encounter as well as stable synapse 
formation could be combined in one model.  
 
The hCRP model allowed us to address another important feature of the adaptive immune 
response, the mutual influence of T cell populations specific for epitopes of the same protein. 
The influence of epitope hierarchy on clonal expansion could be important for the 
understanding of the etiology of autoimmune diseases, which are generally accompanied by 
the recognition of new self-epitopes, a process referred to as ‘epitope spreading’. ‘Epitope’ or 
‘determinant spreading’ was first introduced by Lehmann et al. (1992) to describe the process 
in which an immune response directed to a single self-peptide can spread to include other 
determinants on the same auto-antigen (intramolecular spreading) as well as on other self-
antigens (intermolecular spreading). While dominant epitopes elicit large immune responses, 
subdominant ones elicit smaller ones (Sercarz, 1998). This was also true in the hCRP model. 
Expansion of polyclonal T cell populations with respect to epitope hierarchy and MHC-
peptide competition has recently been subjected to detailed analysis by several groups. Busch 
et al. (1998) showed that distinct endogenous T cell populations specific for Listeria 
monocytogenes-derived epitopes expand, contract and enter the memory compartment at the 
same time. Adoptive transfer experiments have the advantage that defined T cell populations 
can be followed through the response. Therefore the hCRP model provided a useful tool to 
approach the question of clonal influence and expansion under different antigen availability as 
depicted in Figure 17: 
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 Figure 17 Antigen availability in different application modes. (a) reflects the ‘natural’ presence 
of hCRP as found during an acute phase: antigen is applied exogenously by i.v injection and the 
amount necessary to induce a T cell response (threshold indicated by red line) is only transiently 
available. (b) Upon immunization with CFA, the antigen availability is also limited but remains above 
threshold level for a prolonged period of time. (c) In hCRP transgenic animals, antigen is expressed 
endogenously and levels are permanently above threshold. 
 
Data obtained from transfers under non-limiting antigen availability (Figure 17c) were in line 
with those of Busch et al. (1998), in that responses of T cell populations specific for dominant 
and subdominant epitopes expanded with a similar kinetics but differed in their magnitude: 
while dominant epitopes elicited large responses, subdominant epitopes elicited smaller ones. 
Upon co-transfer of both populations, an expansion pattern similar to that obtained from the 
single transfers could be observed (Hommel, 1998). This implies that in a model where 
antigen is abundantly present and therefore both epitopes are presented well above a critical 
threshold, there is no or only minor interference between the populations. In contrast, limited 
antigen availability would be expected to alter the overall epitope presentation and hence the 
outcome of clonal expansion: If antigen was available only transiently, presentation of the 
subdominant epitope would fall below the threshold level necessary to elicit an adaptive 
immune response more quickly or the epitope could even become cryptic. Dominant epitopes 
would be presented at lower levels as well but still high enough to remain above the critical 
threshold. On one hand, this could account for a reduced or aborted response of 
T lymphocytes specific for the subdominant epitope, on the other hand co-transfer of both 
populations could result in intramolecular help, thus elevating presentation of the 
subdominant epitope above threshold (see Figure 18, p66). 
Upon co-transfers under limiting but prolonged conditions (Figure 17b) no differences in the 
time frame or extend of proliferation compared to single transfers could be observed, 
indicating that both epitopes were still presented above threshold. In contrast, short and 
transient antigen availability (Figure 17a) resulted in both populations showing the same 
extent of proliferation upon co-transfer while in single transfers Dep-specific T cells 
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 proliferated much more vigorously than those specific for the subdominant epitope. This 
implicated intramolecular help was taking place. 
 
 
Figure 18 Antigen presentation and intramolecular help. In a situation when antigen is 
prolonged and transiently available, both a dominant (green) and a subdominant epitope (blue) are 
presented above a critical threshold (a). Over time, levels decrease until presentation is no longer 
sufficient to elicit any responses. Is antigen only short and transiently available (b), the number of 
MHC-subdominant epitope complexes is just above or even below the critical threshold, hence 
inducing only weak responses. Upon intramolecular help (c), the response to the subdominant epitope 
is augmented (dotted line). 
 
It is suggested that upon T cell activation, the APC that is engaged in antigen recognition 
receives signals up-regulating the expression of molecules such as MHC class II or co-
stimulators (Sercarz et al., 1993). This in turn could lead to an increased presentation of the 
subdominant epitope and thus provide the possibility of stronger T cell triggering. 
Alternatively cytokines locally secreted by an activated T lymphocyte may stimulate a 
neighbouring T cell on the same APC, specific for a subdominant or cryptic epitope as 
proposed by Mitchison (1990). In the case of experimental autoimmune encephalomyelitis 
(EAE), Yu et al. (1996) found a predictable pattern in which new determinants are 
recognized, and they also showed an invariant relationship between relapse and progression 
of the disease and recognition of new epitopes. Both could be accounted for by an increased 
response to the subdominant epitope as observed in our experiments. While ‘functional’ 
three-cell-type clusters were proposed over ten years ago by Mitchison (1990) and many 
groups have provided indirect evidence for their existence, here we show that the prerequisite 
for intramolecular help was given. 
While the enhanced proliferative capacity of Sep-specific T cells is likely to be the result of 
intramolecular help, how can the finding be explained that at higher antigen doses Dep-
specific T cells peaked about half as high in co-transfer experiments as they did upon transfer 
on their own? Maybe not all of epitope dominance can be explained in terms of affinity for 
MHC and peptide loading as proposed by Chen et al. (2000). There is evidence suggesting 
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 that T cells responding to one antigen can actively interfere in a competitive fashion with 
T cells responding to another (Wolpert et al., 1998; Grufman et al., 1999). Kedl et al. (2000) 
used a model in which endogenous OVA-specific T cells competed with adoptively 
transferred OT-1 TCR-transgenic cells for a dominant and a subdominant OVA epitope in 
vivo. Transfer of OT-I cells, which are of high affinity for the dominant epitope, successfully 
inhibited the endogenous responses to both epitopes – provided they were presented on the 
same APC. Inhibition could be alleviated by transfer of large numbers of antigen-pulsed APC. 
Thus, high affinity T cells efficiently compete for space at the DC and prevent low affinity 
cells from acquiring enough TCR/MHC-peptide interactions. Interestingly, in the absence of 
OT-1 cells little inhibition of the response against either epitope could be observed. The 
authors contributed this to the prediction that low affinity endogenous T cells are inefficient at 
competing with T cells of other specificities. In context of these findings, our data on co-
transfer experiments under short and transient antigen availability suggest the following 
scenario: Proliferation of Dep-specific lymphocytes results in intramolecular help, thereby up-
regulating complexes of MHC-subdominant epitope and reinforcing clonal expansion of Sep-
specific cells. If the latter are of a higher affinity for their epitope, they will now compete with 
Dep-specific lymphocytes for space at the hCRP presenting cells, thus impeding the ‘helper’ 
population. When antigen is available above critical threshold, this effect is abrogated as 
observed. 
The TCR-affinities of both lymphocyte populations have not yet been defined but here we 
have shown that they are very sensitive to low antigen dose: at hCRP concentrations from 
50 µg to as little as 0.5 µg/mouse neither differences in the onset nor in the extent of 
proliferation over time could be observed. Regarding the subdominance of one hCRP epitope, 
this implies rather high TCR affinity. Surprisingly, at concentrations below 0.5 µg/mouse, 
proliferation could not be detected anymore. What could account for these findings? First, we 
do not know whether the amount of antigen arriving in the lymph nodes directly correlates 
with the dose injected into the footpad. Second, it is unknown whether reduction of the 
applied antigen is reflected in a reduction of the overall MHC-peptide density on each 
individual APC or whether the density remains the same and the absolute number of cells 
presenting antigen is reduced (Figure 19). 
A lower epitope density would be likely to result in delaying the onset of proliferation, as the 
previously dominant epitope would now be presented at ‘suboptimal’ levels. The density of 
the previously subdominant epitope may now be below the threshold required for T cell 
commitment, thus completely abolishing clonal expansion. On the other hand, if the number 
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 of APC became limiting but the individual epitope density remained the same, one may 
expect a shift in the extend of proliferation. Since neither a delay in the onset of proliferation 
nor a titration of clonal proliferation was observed, other parameters must influence the 
antigen dose dependency. 
 
 
Figure 19 Antigen distribution at high and low antigen doses. Reduction of the amount of 
antigen used for immunization may result in a decrease of MHC-peptide complexes on each individual 
APC (while the number of APC involved in antigen presentation does not alter) or in a decrease of the 
overall number of APC, each expressing a number of complexes on their surface that is equivalent to 
those at high antigen dose. 
 
Outlook 
 
Upon T cell/DC interaction T cells of either the same or of different specificities are brought 
into close proximity and this provides a prerequisite not only for linked help but also for 
immune deviation as well as the interaction with regulatory T cells (Treg). In particular the 
existence of Treg cells and their mode of action has recently received a lot of attention. It has 
been a great controversy among immunologists, especially due to the ambiguity in the 
molecular basis of suppression. With growing experimental evidence such as the spontaneous 
occurrence of various autoimmune diseases upon depletion of certain CD4+ subsets (reviewed 
by Shevach, 2000), their existence is meanwhile widely accepted and they provide one means 
by which self-reactive T cells are controlled in the periphery. The ability to isolate antigen-
specific T cells at various stages of activation provides a possible means to isolate Treg ex vivo 
at their site of action. 
Furthermore, cluster isolation provides an approach to further dissect the early phase of clonal 
expansion and address issues such the role of synapse formation more closely: In the current 
model proposed by Dustin et al. (2001) synapse formation is regulated by 
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 microenvironmental factors to restrict the site of primary immune responses and to provide a 
control for the duration of T cell/APC interactions. As all data on the establishment of 
synapse formation were obtained from in vitro culture, our approach would offer the 
possibility not only to verify synapse formation in vivo but also to analyze the time-course of 
synapse resolution ex vivo. By combining our approach with video microscope analysis we 
should be able to determine the stability and therefore the duration of cell-cell interaction after 
cluster isolation. Finally, isolating T cell/APC clusters at defined time points should allow 
subjecting cluster-derived, antigen-specific lymphocytes to an extended genetic analysis of 
T cell activation. For example, gene expression patterns of early and late activation events 
could be assessed by gene arrays. This way the in vivo relevance of in vitro observations 
could be validated. 
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Summary (German) 
Zell-Zell-Interaktionen in situ während der frühen Phase der T-Zellaktivierung 
Die erfolgreiche Induktion der adaptiven Immunantwort ist von der Antigendosis, der Dauer 
der Antigenpräsentation sowie der zellulären Mikroumgebung abhängig. Diese Parameter 
können sich je nach Epitop, das von T- oder B-Zellen erkannt wird, voneinander 
unterscheiden. Das in situ Verhalten klonaler T-Zellpopulationen ist erst in den letzten Jahren 
der präzisen Analyse zugänglich geworden. So konnte gezeigt werden, daß Cluster 
proliferierender Zellen um dendritische Zellen (DZ) herum lokalisiert sind, die die MHC 
Klasse II-exprimierenden antigen-präsentierenden Zellen (APZ) in der parakortikalen Region 
des Lymphknotens ausmachen. Eingewanderte T-Zellen interagieren mit DZ und erscheinen 
aggregiert. Die Isolation solcher Aggregate aus dem Thymus ist bereits beschrieben worden. 
Hier wurde diese Methode adaptiert und modifiziert, und es war zum ersten Mal möglich, 
eine Verbindung zwischen veröffentlichten in vitro und in situ Studien herzustellen. Das Ziel 
dieser Arbeit war es, T-Zell/APZ Cluster aus Lymphknoten von Mäusen zu isolieren und als 
Kompartment der T-Zellaktivierung zu charakterisieren. Die frühe Phase der klonalen 
T-Zellexpansion im Hinblick auf Lokalisation und Kinetik wurde analysiert. 
 
Isolation und Charakterisierung von Clustern 
Cluster wurden aus drainierenden Lymphknoten von CFA-immunisierten Tieren oder 
Mäusen, die mit Antigen/CFA immunisiert worden waren und im Anschluß antigen-
spezifische T-Zellen erhalten hatten, isoliert. Die Lymphknoten wurden zu verschiedenen 
Zeiten herausgenommen, das Gewebe mit Kollagenase/Dispase verdaut und die Cluster 
anschließend über einen 1 x g Gradienten angereichert. DZ konnten über den 
Oberflächenmarker CD11c identifiziert werden und fungierten in etwa 70% der Cluster als 
zentrale Zelle. Die durchschnittliche Anzahl der T-Zellen pro Cluster lag bei etwa 10-20. Die 
Clusterbildung an sich war nicht strikt antigenabhängig – auch aus mesenterialen 
Lymphknoten unbehandelter Tiere konnten sie in kleiner Anzahl gewonnen werden (wobei 
hier eine natürliche Infektion nicht ausgeschlossen werden kann) –, allerdings stieg die 
Anzahl nach Immunisierung stark an. 
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 Phänotypische Analyse der cluster-assoziierten T-Zellen 
Interessanterweise ging die Clusterbildung mit einer Segregation erst kürzlich in den 
Lymphknoten eingewanderten T-Zellen einher: Wie anhand der Färbung des Homing-
markers CD62L, der auf naiven, rezirkulierenden Lymphozyten exprimiert und bei Eintritt in 
den Lymphknoten herunterreguliert wird, deutlich wurde, konnte seine verminderte 
Expression nur auf cluster-assoziierten, nicht jedoch auf freien T-Zellen nachgewiesen 
werden. In Mäusen, die mit Antigen immunisiert worden waren und einen T-Zelltransfer 
erhalten hatten, konnte außerdem eine Segregation antigenspezifischer Cluster gezeigt 
werden. Während der Gesamtanteil an transferierten Zellen relativ gering war, lag die Anzahl 
der Cluster, die mehrere dieser Zellen enthielten, hoch. Dies war besonders zum Zeitpunkt der 
ersten Teilung sehr ausgeprägt. Desweiteren konnte die Aktivierung von T-Zellen direkt mit 
der Notwendigkeit der Zell-Zell-Interaktion korreliert werden, denn nur T-Lymphozyten aus 
T-Zell/APZ Aggregaten zeigten Aktivierungsmerkmale wie die starke Oberflächenexpression 
von CD69, einem frühen Marker, sowie CD25, das erst später hochreguliert wird. Dieser 
Befund konnte in vier verschiedenen Modellen bestätigt werden.  
 
Cluster als ‘funktionelle Einheiten’ der T-Zellaktivierung 
Experimente mit CFSE-markierten T-Zellen zeigten, daß 12-16 Stunden nach Transfer die 
ersten Lymphozyten in Clustern lokalisiert werden konnten und nach weiteren 18-20 Stunden 
ihre erste Teilung durchlaufen hatten. Diese APZ-abhängige Anfangsphase der Proliferation 
wurde später von einer vom Zell-Zell-Kontakt unabhängigen Phase abgelöst. Insgesamt 
benötigte die ‚T-Zellwelle’ (auf Einzelzellebene konnte eine Analyse mit unserer Methode 
nicht durchgeführt werden) vom ersten Kontakt an ca. 32-36 Stunden, um das 
Clusterkompartment zu durchlaufen. Dieser Zeitrahmen war invariant und konnte in 
verschiedenen Modellen bestätigt werden, die sowohl beide T-Zelllinien (CD4, CD8) als auch 
zwei unterschiedliche MHC-Typen (H2b,H2d) umfassen. Darüber hinaus konnte beobachtet 
werden, daß T-Zellen, die für ein subdominantes Epitop und einen schwachen Agonisten 
spezifisch sind, eine gegenüber Lymphozyten, die ein dominantes Epitop erkennen, längere 
Zeitspanne brauchten, um die erste Zellteilung zu vollenden. 
 
Das hCRP Modell: Cluster bieten eine Möglichkeit der Zellkommunikation 
Eine wichtige Voraussetzung für die Kommunikation zwischen an einer adaptiven 
Immunantwort teilnehmenden Lymphozytenpopulationen ist die Präsentation der von ihnen 
erkannten Epitope auf ein und derselben APZ. Mit unserem Ansatz der Cluster-Isolierung und 
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 dem Vorteil, im hCRP-Modell auf klonale T-Zellpopulationen mit Spezifität für zwei Epitope 
desselben Proteins zurückgreifen zu können, konnten wir zum ersten Mal zeigen, daß diese 
Konstellation in vivo existiert. Dies bot uns die Möglichkeit, den gegenseitigen Einfluß beider 
Populationen unter verschiedenen Bedingungen der Antigenverfügbarkeit zu untersuchen. In 
vorangegangenen Experimenten konnte gezeigt werden, daß sowohl bei Transfer nach 
Immunisierung als auch in antigenexprimierende Tiere die klonale Expansion von Zellen, die 
das dominante Epitop von hCRP erkennen, etwas höher war, als die der Zellen, die gegen das 
subdominante gerichtet waren. In beiden Fällen konnte kein gegenseitiger Einfluß nach Ko-
Transfer beobachtet werden. Wurde das Antigen bei Immunisierung titriert, hatte dieses bis zu 
einer bestimmten Dosis bei beiden Populationen weder Einfluß auf den Zeitpunkt des 
Proliferationsbeginns noch auf deren Ausmaß. Wenn das Antigen intravenös appliziert wurde, 
also nur für sehr kurze Zeit verfügbar war, war die Antwort der gegen das dominante Epitop 
gerichteten Zellen in einer dosisabhängigen Weise wesentlich ausgeprägter als die der gegen 
das subdominante gerichteten Lymphozyten. Interessanterweise konnte bei Ko-Transfer unter 
diesen antigenlimitierenden Bedingungen eine deutlich erhöhte Expansion der für das 
subdominante Epitop spezifischen Zellen beobachtet werden. 
Zusammenfassend sei angemerkt, daß die hier gezeigten Ergebnisse im Kontext der aktuellen 
Literatur eine Möglichkeit bieten, derzeitige Modelle der T-Zellaktivierung in einem neuen, 
erweiterten Modell zu vereinigen. Darüber hinaus stellt der Ansatz der Clusterisolierung eine 
Methode dar, die in Verbindung mit anderen experimentellen Ansätzen genutzt werden kann, 
um wichtige Fragen der frühen T-Zellaktivierung im Detail zu untersuchen. 
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Abbreviations 
aa amino acids 
AICD activation induced cell death 
Ag antigen 
APC antigen presenting cell(s) 
bp base pairs 
BrdU bromodesoxyuridine 
ccpm Cerenkov counts per minute 
CD cluster of differentiation (cell surface markers) 
CD25 IL-2 receptor β-chain 
CD62L L-selectin 
CFA complete Freund’s adjuvant 
Ci Curie 
conc. concentrated 
CRP C-reactive protein 
cTEC cortical thymic epithelial cells 
CTL cytotoxic T-lymphocytes 
dATP desoxy-adenosine-triphosphate 
dCTP desoxy-cytidine-triphosphate 
dGTP desoxy-guanosine-triphosphate 
dTTP desoxy-thymidine-triphosphate 
DC dendritic cell(s)  
DMSO dimethylsulfoxide 
DNA desoxyribonucleic acid 
dNTPS 1:1:1:1 mixture of dATP, dCTP, dGTP, dTTP 
EDTA ethylene-diamine-tetra-acetate 
e.g. for example 
ELISA enzyme-linked immunosorbent assay 
FACS fluorescence activated cell sorting/ scan 
FCS fetal calf serum 
FDC follicular dendritc cells 
Fig. figure 
FITC fluoresceine-isothiocyanate 
Gy Gray; unit of radioative dosis; 1 Gy = 100 rad 
hCRP human C-reactive protein 
HEPES 4-(2-hydroxyethyl)1-piperazine-ethanesulfonic acid 
HLA human leukocyte antigen 
3H-Td 3H-thymidine 
ICAM intercellular adhesion molecule-1 
i.e. that means 
IFN-γ interferon-gamma 
Ig immunoglobulin 
IL interleukin 
IS immunological synapse 
i.v. intravenous 
LC Langerhans cell 
LFA-1 lymphocyte function-associated antigen-1 
LPS lipopolysaccharide 
Mφ macrophage 
mAb monoclonal antibody 
MACS magnet-activated cell sorting 
max. maximum 
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 MBP myelin basic protein 
mCRP mouse C-reactive protein 
MHC major histocompatibility complex 
min. minimum 
mSAP mouse serum amyloid protein 
mTEC medullary thymic epithelial cells 
MTOC microtubuli organizing center 
NK natural killer cell 
OD optical density 
o/n over night 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PE phycoerythrin 
rpm rounds per minute 
RT room temperature 
s seconds 
SDS sodium dodecylsulfate 
SMAC supramolecular activation cluster 
SSC sodium chloride/sodium citrate 
TAE tris/acetate/EDTA 
TCR T cell receptor 
tg transgenic 
TGF-β transforming growth factor-β 
Th0 IL-2-secreting T effector cells 
Th1 T helper 1 
Th2 T helper 2 
Tris trihydroxy-methylamino-methane 
TCR T cell receptor 
Treg  T regulator cells 
UV ultra violet 
VCAM vascular cell adhesion molecule 
VLA very late antigen(s) 
v/v volume per volume 
w/v weight per volume 
w/w weight per weight 
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